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ABSTRACT 
 
 
Proteins are involved in nearly every process that occurs in living systems, either as a 
main participant in the process or preforming a supporting role. It is estimated that 
approximately half of proteins in living systems are associated with a metal in some fashion. 
With such a high percentage of proteins interacting with metals, it may not be a surprise that 
most cellular pathways that  have at least one metalloprotein performing one or more steps. 
Many, if not all, of the most important and complex processes that occur in living systems are 
performed by a metalloprotein. These processes include photosynthesis, cellular respiration, and 
nucleic acid repair. The metals in these proteins expand the potential chemistry beyond what can 
be done with only the 20 naturally occurring amino acids. However, nature uses relatively few 
metal complexes, such as heme cofactors or iron sulfur clusters or metal ions, considering the 
number of functions that metalloproteins perform. Also, nature uses a surprisingly small number 
of protein domains and folds compared the number of possible folds. In metalloproteins, both the 
metal and protein environment surrounding it play an important role in determining the 
chemistry that is performed. The protein adjusts the properties of the metal, such as the redox 
potential or the number of open coordination sites. Many metal ions found in metalloproteins are 
less reactive outside of a protein environment. Despite many years of study, we are only 
beginning to understand the functioning of large complex metalloproteins, such as heme copper 
oxidases (HCOs) in respiration or the oxygen evolving complex in photosystems. Large complex 
proteins pose two problems with respect to studying function. Large complexes are relatively 
difficult to isolate in a biologically relevant form and the multiple metal sites can either interfere 
with spectroscopic analysis or require the use of relatively sophisticated methodology.  
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As an alternative to studying these complex proteins, we have chosen instead to redesign 
an existing well-studied heme protein, myoglobin, to mimic the bimetallic, heme-CuB site of 
HCOs. This is the site where molecular oxygen is converted to water as part of cellular 
respiration. The conversion of oxygen to water is highly difficult as there are many highly 
reactive intermediates that must stabilized so that the reaction can result in water formation. Such 
a redesign can be thought of as going from the “bottom up” with respect to the desired function.  
In the process of building up such a model, we are producing minimalistic versions in order to 
see what the function of each of the structural features is and how it affects chemistry.  
This thesis describes the improvement of an existing myoglobin based model system of 
HCOs, named CuBMb, where an non-native copper site was previously engineered into 
myoglobin by adding two histidine residues. Along with the native histidine, the resulting site  
resembles the CuB site found in HCOs. This model protein is purified without metal in the CuB 
site and therefore it is possible to determine the role of the bound metal and the effect of using 
other metals. Previous studies of this model have not observed the desired chemistry, production 
of water from oxygen. However, HCOs have a novel feature found in no other proteins, namely a 
covalently attached histidine and tyrosine moiety that is critical for function of HCOs in vivo. To 
roughly mimic this novel feature, a tyrosine was introduced into CuBMb at various locations in 
the designed heme-CuB site. To guide the selection of the positions to place our tyrosine we used 
both the amino acid sequence information of HCOs and computer based protein models of 
myoglobin with a tyrosine. The computer models were compared to reported crystal structures of 
HCOs. The most similar mutants were made and characterized. The resulting tyrosine containing 
CuBMbs displayed the ability to produce water from oxygen, despite the absence of the covalent 
bond between tyrosine and one of the hisitidines used to bind the copper, as in HCOs. Even more 
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unexpectedly the desired activity was observed without the copper in the CuB site.. This result is 
both interesting and unexpected.  To futher improve the observed rate, more features of HCOs 
such as proton delivery channels and non-natural heme cofactors with similar features compared 
to heme cofactors found in HCOs were introduced into myoglobin.  The proton channels had 
positive effects on the observed activity.  In addition to these interesting results, attempts were 
made to try and react the tyrosine containing CuBMbs under various conditions to induce 
formation of a covalent bond analogous to the crosslinked histidine and tyrosine found in HCOs. 
In the process, a crystal structure of a novel species, where an oxygen species is bound “side-on” 
to the metal of the heme cofactor instead of the expected “end-on” mode that to our knowledge 
has never been observed in a heme protein. 
In  summary, to better understand the functioning complex proteins like HCOs, a model 
protein was previously constructed. Introduction of new structural features, into the model 
protein (CuBMb), with the purpose of mimicking features similar to those found in found in 
HCOs caused the model system to become competent to perform the desired chemistry with less 
features than what is thought to be required in HCOs. As more features were attempted we 
discovered an interesting oxygen species bound to our protein. These type of results show the  
advantage of trying to build upto a minimal model. It is possible with such a system to obtain 
unique proteins and intermediates in addition to what information one is attempting elucidate. 
One is also able to perform experiments that would be impossible in the native system and obtain 
useful information. The insights gained by this modeling work will help the designers of the next 
version of CuBMb overcome the limitations of this version and gain insight into how to generally 
build and design metalloproteins. 
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CHAPTER 1 
INTRODUCTION 
1.1 A brief introduction to metalloproteins 
Proteins are the catalysts of choice for effectively all of the critical processes in living 
systems ranging from signal transduction to energy conversion and utilization. In a recent report, 
it was shown that greater than half of the proteins expressed in living systems contain some form 
of metal cofactor, or are otherwise associated with a metal1. The function of these metal 
cofactors can range from being merely structural2,3, to transferring electrons4, to directly 
interacting with and chemically modifying bound substrates5. While metals are vital to the 
functioning of metalloproteins, the surrounding protein environment is also critical in 
determining and facilitating function. For example, in zinc fingers3,  and metal sensing proteins2 
the metal plays a structural role but the resulting difference in protein conformation can alter 
interactions with other macromolecules and effect processes like gene transcription. When 
removed from the protein environment, the cofactors no longer function effectively in most 
cases. Furthermore, changes to the ligand set within the protein and even changes to the 
surrounding, long-range, hydrogen bonding, hydrophobic or ionic interactions can be altered in 
order to alter or introduce new functionality into a protein scaffold.  
1.2 CcO/HCO activity and function and structural features  
 Living systems must produce large quantities of high energy molecules, like adenosine 
triphosphate (ATP), in order to store and transfer chemical energy and facilitate the production 
of molecules vital for life. In aerobic organisms, the reduction of oxygen to water is coupled to 
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translocation of protons across the inner mitochondrial membrane to create a proton gradient6,7, 
which is then used to drive the production ATP. The class of enzymes responsible for the 
conversion of oxygen to water is the heme copper oxidases (HCOs)5. These enzymes bind 
oxygen at a heme site with a nearby secondary metal site, known to contain a copper atom. The 
oxygen is then efficiently reduced to water, with little to no production of partially reduced, 
reactive oxygen species, with electrons that are transferred through two alternate metal sites. The 
electron transfer events are then coupled to proton transfer through the protein and across the 
inter-mitochondrial membrane.  
While HCOs have been extensively studied8-13, detailed studies of the inner workings of 
these proteins are difficult 14. All of the proteins in this class are large transmembrane proteins, 
the mass of bovine CcO is ~200,000 Da, 14,15(see figure 1.1), which make these proteins difficult 
to express and purify in large yield. The other metal based electron transfer sites also have 
similar electron absorption spectra as compared to the catalytic site, which convolutes the 
spectroscopy. Modeling the metal sites of HCO proteins individually in smaller systems is, 
therefore, critical to understanding the intricacies of these proteins. 
In order to effectively model features of HCO proteins, an understanding of the important 
features in native HCOs is critical. In native HCOs, subunit I contains the heme-CuB site5, where 
oxygen binds, which consists of a His ligated heme cofactor and Cu atom ligated by 3 His 
residues, known as the CuB site. The role of the copper in the site is to transfer the second 
electron to bound oxygen14. Mutations that affect copper binding inhibit activity of HCOs. One 
of the His ligands of the CuB site is covalently attached to a nearby tyrosine residue by a novel 
His-Tyr cross-link, which has only been observed in HCOs. In many HCOs, the a-type and b-
type HCOs5,12, the covalently attached His and Tyr residues are separated by 4 residues in the 
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protein sequence. However, in c-type HCOs, the His and Tyr are on separate helices16. Subunit I 
also contains a 6 coordinate low spin heme cofactor that is the intermediate step in the transfer of 
electrons from a dicopper site, CuA, in Subunit II, to the heme cofactor in the heme-CuB site. 
The Heme-CuB12 site is located deep within the lipid bilayer, which requires that a proton 
channel exist for efficient transfer of protons to the site for oxygen reduction.  
 
Figure 1.1 Crystal structure of Bovine CcO (PDB 1V54). Subunit I containing the heme CuB site is colored blue. 
Subunit II containing the CuA site is in purple. Locations of metal sites are indicated by red circles. All other 
subunits are in cyan. Coppers are represented as brown spheres 
1.3 Synthetic model systems for studying HCOs  
As mentioned above, the HCOs are large transmembrane proteins that are integral to the 
production of ATP in aerobic organisms. Study of these proteins is also complicated by the fact 
that HCOs have multiple metal containing sites and contain at least 2 heme cofactors. The heme-
CuB site, where the reduction of oxygen to water occurs12, has been the extensively studied, but 
the fine details of the intermediates involved in HCOs are often difficult to elucidate due the 
CuA
CuB
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complexity of the enzyme14. The multiple heme cofactors, in particular, are problematic as subtle 
changes at one site can be masked by an overlapping signal from the other site. As an alternative 
to studying the native HCOs, synthetic models of only the heme-CuB site have been constructed. 
Recently, some of these model systems have been shown to perform oxygen reduction17,18. These 
model systems typically consist of Fe containing porphyrin molecules, mimicking the heme of 
the heme-CuB site19, with either covalently attached linkers connecting His analogs18 (commonly 
pyridine or methyl histidine) or non-covalently attached with pyridine complexes that bind 
tridentate to the copper serving as a CuB site analog20,21. The non-covalent CuB analogs use the 
oxygen binding affinity of the heme and copper sites to ensure proximity20. Some of the more 
sophisticated versions of these synthetic systems contain an analog of the novel His-Tyr linkage 
seen in HCOs18,22-24. These systems represent the bare minimum that is required for HCO like 
oxygen reduction, with the hydrophobic protein environment mimicked with organic solvent. 
Work by Collman and coworkers18,22 reported the first active HCO model and characterized their 
model system with and without copper and with and without a cross-linked His-Tyr analog but 
not with the Tyr present, but unattached to the His.  
However, these large synthetic model complexes, are not well suited to physiological 
conditions, making them less relevant to the biological system. In addition, study of the roles of 
other features, such as the proton channels is impossible to reproduce in such systems as each 
variation would potentially require a different synthetic approach for each version and the 
insolubility of such complexes in water makes delivery of protons in a biologically relevant way 
impossible. Furthermore, longer-range interactions, like hydrogen bonding from nearby residues, 
which are known to be critical for fine-tuning protein function, cannot be studied in such systems 
because synthetic molecules are typically limited in size and the number of functional groups 
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that may be incorporated. As such, a semi-synthetic approach using small scaffold proteins, 
outlined below, to accommodate the important feature of the heme-CuB site in an environment 
where such properties can be investigated was employed here. 
1.4 Protein design methodology 
 Protein design and engineering offers the potential to create proteins unseen in nature 
with functions not seen in nature25, or proteins with the same function but better suited for either 
study or practical application. While the ultimate goal of protein design would be to design a 
protein from the primary amino acid sequence26,27, i.e. de novo protein design, where a protein 
could be designed from scratch and contain all the functional features of the protein of interest. 
The ability to design proteins in such a way is limited, however, by current knowledge of protein 
folding28.  
As an alternative to completely de novo protein design, the use of native proteins as 
scaffolds28-33, into which the functional elements of another protein can be incorporated. This 
method is aided by the fact that there are several thousand different scaffold types currently 
known. With the development of methodologies such as site directed mutagenesis the alteration 
of existing proteins sequences has become relatively simple. Therefore, the rational alteration of 
a known protein function should be achievable given a clear target activity and a protein having 
the desired function to emulate. It should be noted that more information that is known about the 
effects of mutagenesis on given “scaffold protein” particularly point mutations in a given region 
or position the more effective methodologies of this nature will be. Computer based protein 
design methodologies, using programs such as Visual Molecular Dynamics34 (VMD) and 
Scalable Molecular Dynamics (NAMD)35 or the Rosetta software package36, provides guidance 
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in the selection of given the point mutations to introduce proteins. Studies where computer aided 
rational redesign of native proteins has been employed have been successful, such as in the 
engineering of myoglobin into a structural and functional mimic of NOR31 (described below in 
section 1.1.5.3). Another prominent example computer based design work comes from the work 
of David Baker’s lab where they successfully made proteins with functions not seen in any 
known natural protein25. The advantage of such methodologies is that with proper parameters the 
equivalent of saturation mutagenesis at multiple sites can be performed and analyzed in silico. 
However, with any computer based protein design method confirmation by experimental work is 
highly important. With these tools, the rational design of proteins that mimic or model more 
complex protein from the “bottom up” is achievable. The advantage of such methodologies is 
that functions assigned by other models or by top down methodologies, i.e., classical 
biochemistry where something functional is altered to infer function, can be tested and confirmed 
or reassigned. The bottom up methodology tests if what is thought to impart function truly does.  
1.5 Selected protein engineering studies in myoglobin and previous work on CuBMb 
1.5.1 Selection of a proper protein scaffold for modeling HCOs 
Engineering functionality into a protein that does not natively exhibit the desired 
functionality is highly complex and requires that an appropriate scaffold protein first be chosen 
from the thousands of choices available28. Any scaffold must satisfy many criteria to be 
considered for protein engineering. In the case of modeling the heme-CuB site of HCO proteins, 
the scaffold protein must be readily isolated in high yield and not have multiple interfering 
chromophores that will overlap in spectroscopic studies. The scaffold protein must also be highly 
stable and able to withstand the many mutations required to introduce new activity. The scaffold 
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protein must also be, in this case, a heme protein capable of binding oxygen, as oxygen is the 
substrate. For modeling of the HCO heme-CuB site, the small heme protein myoglobin (Mb) was 
chosen as a scaffold. 
Myoglobin is a very well-characterized small heme protein37, ~17 kDa, whose natural 
function is oxygen storage. Mb is a highly stable protein and has been extensively mutated38-40. 
Such a vast library of studied mutations and their effects also provides an excellent knowledge 
base from which to draw from when considering further mutations to construct. In addition, Mb 
is relatively easy to crystalize41, which allows for easy structural characterization of variants, and 
its spectroscopic features have been thoroughly investigated making characterization of reactive 
intermediates easier37. Furthermore, Mb has been previously used as a scaffold32,42, into which 
various functions have been designed. Described below are previous studies where myoglobin’s 
oxygen based chemistry has been altered by point mutations and replacement of the native heme 
cofactor to gain insight into the function of other heme proteins or introduce new function. 
1.5.2 Conversion of myoglobin into a peroxidase and peroxygenase 
Work by Watanabe and coworkers focused on the enhancement of Mb based peroxidase43 
activity. Mutations showed that naturally occurring peroxidase activity of sperm whale Mb 
(swMb) can be enhanced by site directed mutagenesis. The mutations were chosen based on 
comparisions between oxygen bound structures of swMb and cytochrome c peroxidase (CcP). 
The distal histidine, His64, of Mb was mutated to Leu and a His residue was introduced at either 
residue 29 (L29H) or residue 43 (F43H). A nearby His in CcP is known to be critical in 
peroxidase functionality by aiding in cleavage of the oxygen-oxygen bond of hydrogen peroxide 
through hydrogen bonding, while the Leu mutation increased the lifetime of cpd I by preventing 
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radical formation at His6443. His29 in Mb was found to be too far away to enhance peroxidase 
activity, but His43 did enhance activity, as it has a similar distance to the bound oxygen as the 
His in CcP. This F43H/H64L myoglobin displays increased peroxidase activity44 and oxidizes 
Guaiacol and ABTS.  
Additional work by Watanabe and coworkers in myoglobin include the engineering of 
p450 like chemistry by rational design. The first mutations performed involved mutation of His 
64 as part of an attempt to mimic the activity of chloroperoxidase from Caldariomyces fumago in 
Mb, which is known to have an Asp residue near the active site that is important for activity. The 
incorporation of H64D45 into myoglobin resulted in increased peroxidase and peroxygenase 
activity by 78- and 580- fold respectively. This study is a good example of how one point 
mutation carefully selected point mutation can substantially change activity. A series of 
mutations were then tested to fine-tune the H64D mutant46,47 based on observations that position 
68 can affect binding properties of ligands in myoglobin48. Mutation of Val 68 to Ile was found 
to give the best increase in activity even compared to the Leu mutation. This study highlights 
that even subtle differences in animo acid side chains affect reactivity. The incorporation of the 
F43W mutation also resulted in increased peroxidase and peroxygenase activity in Mb49 of 3- 
and 20- fold respectively over both wild type and H64L Mb background. The Trp43 in 
F43W/H64L Mb oxidized was during reaction to 2,6-dihydro-2,6-dioxoindole50 based on NMR 
spectroscopy. The F43W/H64D/V68I mutant (WDI Mb) was made by incorporation of F43W 
into the above mentioned H64D/V68I background32. The Trp43 of WDI Mb was shown to be 
stoichiometrically oxidized by hydrogen peroxide. This observation allowed for isolation and 
characterization of the +16 Da product, unable to isolated in the previous study. This study was 
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the first to demonstrate preferential hydroxylation of the 6 position of Trp. The WDI Mb study 
confirmed the proposal of mechanism of 2,6-dihydro-2,6-dioxoindole50  proposed previously. 
1.5.3. Study of NORs by altering CuBMb 
There is a high level of similarity between HCOs and bacterial nitric oxide reductases 
(NORs).51 Differences, however, based on modeling and sequence homology are the presence of 
additional glutamic acid residues near the heme cofactor and non-heme iron site, i.e. the FeB 
site52-54 and the absence of the His-Tyr cross-link of HCOs. CuBMb is a myoglobin based model 
of HCOs described below in section 1.1.5.4. Lu and coworkers 31 modeled bacterial NORs based 
on the similarities between NORs and HCOs. A glutamate residue was  therefore added to 
CuBMb at position 68 in the place of valine, and the resulting protein was called FeBMb. As 
there was no crystal structure of bacterial NORs at the time for overlay and comparison, an 
energy minimized computer model of FeBMb was made, using Zn in the model as a Fe analog. A 
crystal structure of Fe bound FeBMb was also obtained that confirmed the computer modeling. 
FeBMb displays the activity of NORs, ie the conversion of two NO to N2O and H2O. Making 
FeBMb the first model of NORs that is both structurally and functionally consistent with NORs. 
This study shows that the chemistry of large complex transmembrane proteins such as NORs and 
HCOs can be successfully reproduced in a much smaller Mb based system. In fact, the a high 
degree of structural similarities between FeBMb and c type NORs (cNORs) was later 
confirmed51 when the crystal structure of the NOR from Pseudomonas aeruginosa was 
crystalized in complex with antibodies.  
As a futher extension of cNOR modeling an additional Glu residue55 was added into the 
heme pocket to see how NOR activity was affected as previous studies of NORs suggested 
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multiple Glu residues may be present in the heme-FeB site of NOR52-54. The main difference 
between the Glu residue at position 68 and the additional Glu at position 107 is that the new Glu 
residue is not a ligand to the metal site. The effect of the mutation however is substantial in that 
it doubles the rate of NOR activity compared to the original FeBMb. As the I107E mutant does 
not significantly alter the redox potential to protein it is likely involved in proton transfer via a 
hydrogen bonding network. This additional work on top of FeBMb shows that features such as 
hydrogen bonding networks and other secondary coordination sphere features can be rationally 
designed with careful selection of point mutations. 
1.5.4 Design and previously reported work on CuBMb 
The work described above showed that engineered His residues in the distal pocket of Mb 
can have a dramatic effect on the function of the protein. Similar in nature to the work described 
above, Sigman et al.56 engineered multiple His residues into the heme pocket of myoglobin, in 
order to build a heme-CuB site similar to that in HCOs. The mutations made were chosen based 
on overlays of crystal structures of WTswMb and bovine cytochrome c oxidase. Two mutations 
of amino acid sidechains to His , L29H and F43H, were introduced into the Mb scaffold to form 
a tris-His metal binding site along with the native distal His in Mb, His64 (Figure 1.2). Because 
this site is similar to the CuB site of HCOs, this Mb variant with the tris-His site will be referred 
to as CuBMb56, although the secondary metal site should be regarded as free of metal, unless 
otherwise noted. 
11 
 
 
Figure1.2 Comparison of (A) the heme-CuB site of bovine CcO (PDB 1V54), (B) Heme pocket of WT swMb (PDB 
1JP6) and (C) heme pocket of CuBMb 
As mentioned above, the copper in the site CuB of HCOs has been shown to provide a 
second electron to the bound oxygen in the reduction of oxygen to water, and is critical for native 
HCO function. This engineered site is similar to the CuB site in HCOs, in that the positioning of 
bound copper binding site is ~5Å from the heme iron56. The engineered protein does display 
weaker oxygen binding compared to wild type myoglobin, but binds copper with a Kd ~ 9 µM . 
An major advantage of studying CuBMb as opposed to native HCOs is that it CuBMb is not 
purified with a metal in the CuB site. This feature allows for the placement of any metal in the 
CuB site, which cannot be done in native HCOs. Positioning of copper in the engineered site was 
confirmed using EPR to demonstrate antiferromagnetic coupling between cyanide bound heme 
iron and added Cu56.  
 When myoglobin is reduced by ascorbate in the presence of TMPD as a mediator it binds 
oxygen and forms oxyMb in tris-HCl at pH 8 similarly to WTswMb. However, CuBMb also 
displays copper dependent oxygen chemistry that WTswMb does not57. In the absence of 
catalase, OxyMb reacts with hydrogen peroxide to form verdoheme58,59. In the presence of 
catalase the hydrogen peroxide is degraded and OxyMb is stable. CuBMb mutations did not 
A B C
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prevent oxygen binding, however the oxygen affinity CuBMb as demonstrated by a small 
deoxyMb shoulder in the soret band57. The addition of Ag(I) can restore wild type like oxygen 
binding as evidenced by the 418nm soret band with little or no deoxy shoulder. In the presence 
of Cu, heme oxygenase chemistry is observed as evidenced by a decrease in the intensity of the 
soret band and an increase in absorbance at 622 nm and 678 nm.  
This copper dependent chemistry is interesting, not only because wild type myoglobin 
doesn’t display this, but also because heme oxygenase chemistry60,61 shares a ferric hydroperoxo 
intermediate, also known as cpd 0, with HCO chemistry57. If this intermediate remains 
unprotonated it will cause degradation of the heme cofactor forming verdoheme and bilverdin 
via heme oxygenase chemistry.  If protonated, the dioxygen bond would likely cleave 
heterolytically forming cpd I, i.e. ferryl heme with a cation radical and proceed toward HCO like 
chemistry. The formation of such an intermediate from oxygen bound myoglobin would require 
an electron and a proton transferred to OxyMb57. Based on studies of wild type myoglobin, the 
protonation of the bound oxygen typically causes release of superoxide62. However, for reduction 
of oxygen to water protonation of the bound species must occur. Therefore the protein must 
coordinate electron and proton delivery carefully to avoid undesired chemistry. In the initial 
generation of the CuBMb catalyst, the chemistry seen indicated that while electron transfer 
occurred, introduction of protons was problematic. The inability of transfer protons as needed 
leads away from HCO activity and towards heme oxygenase chemistry61. Building other 
functional pieces of HCO proteins into the CuBMb scaffold, therefore, became a large priority.  
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1.5.5 Replacement of heme b with a mimic of o type heme 
One element that was missing from the original CuBMb system was a hydrogen bonding 
network to deliver protons to the catalytic site from bulk solvent. In an effort to create a more 
complete hydrogen bonding network in CuBMb and avoid heme oxygenase chemistry by 
increasing the likelihood of protonation of Cpd 0, the native heme b of myoglobin was replaced 
with an unnatural heme63, having a hydroxyethyl in the place of a vinyl group n heme b. The 
inspiration for this study was taken from the fact that different HCOs natively vary in the type of 
heme located in the Heme-CuB site5. The a/o type hemes of aa3, ba3, and bo3 oxidases contain a 
hydroxyfarnesyl group that is within hydrogen bonding distance of both the novel cross-linked 
His-Tyr and positioned at the end of the K-channel12,64, which has been implicated in the 
delivery of protons into the heme-CuB site65,66. Proposed catalytic mechanisms of HCO proteins 
suggest a hydrogen bonding network with the hydroxyfarnesyl hydroxyl and water molecules 
bridging the bound oxygen and the tyrosine hydroxyl. Other HCOs, such as bb3 types8, contain a 
b type heme, like myoglobin does, that lacks the hyrdroxyfarnesyl group. These HCOs 
compensate by having a nearby Tyr residue supply the hydroxyl group needed. 
Another attractive feature of the CuBMb system is that the heme cofactor in myoglobin 
can be replaced by unnatural hemes to study the effects different cofactors have on oxygen 
chemistry67,68. Lu and coworkers63 took advantage of this feature of myoglobin by replacing the 
b type heme of myoglobin with a mimic of o type heme o (Fe(III)-2,4 (4,2) hydroxyethyl vinyl 
deuterioporphyrin IX) that replaces a vinyl group of heme b with a hydroxyethyl group to 
analogous that of the hydroxyl of the o type heme. CuBMb containing heme o mimic, denoted as 
CuBMb(o) slowed the copper dependent heme oxygenase chemistry of by approximately 19-
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fold. Suggesting that the hydrogen bonding network was altered in CuBMb(o) by the unnatural 
cofactor and that this network regulates activity in HCOs. 
1.6 Thesis goals and outlook 
While several interesting features were observed in the CuBMb system, it still failed to 
meet the goal of performing as a viable mimic of HCO proteins. The goal of the work described 
in the following chapters is, therefore, to improve upon the CuBMb model system described 
above, thus making a functional and more accurate model of HCOs. Chapter 2 describes work 
aimed at introducing a tyrosine positioned similarly to the His-Tyr crosslinked amino acids 
observed in HCO and observing the effect of introduced tyrosine on the activity of CuBMb. It 
was seen that the tyrosine containing variants of CuBMb display the ability to consume oxygen 
and convert it to water, mimicking HCO activity. Presumably by affecting the hydrogen bonding 
network. It was also observed that the rate of activity is dependent upon the location of the 
tyrosine introduced. Chapter 3 describes work towards improving the activity observed in 
Chapter 2 by further expanding the hydrogen bonding network in the distal pocket of myoglobin 
by two methods. The first is by replacing heme b with the mimic of the o type heme described 
above. The second involves making additional point mutations to create a hydrophilic channel 
from the bulk solution to heme pocket to deliver protons to the heme CuB site. Chapter 4 is a 
summary of progress toward the formation of a His-Tyr crosslink, analogous to the one found in 
HCOs into CuBMb with the ultimate purpose of studying the effects on activity in comparison to 
the results of work in the preceding chapters. Chapter 5 describes the observation, via 
crystallography, of a side-on bound oxygen species bound to heme iron, this is the first direct  
observation of such a feature in a heme protein, although such features have been proposed in 
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some heme proteins. The chapter also discusses initial spectroscopic characterization of this 
novel species. 
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CHAPTER 2 
OXYGEN CHEMISTRY OF CUBMB AND THE EFFECT OF INTRODUCING 
TYROSINE RESIDUES INTO THE CUBMB SITE 
Portions of this chapter a taken from the final draft of a manuscript submitted to Proc Natl Acad Sci USA as “A 
Designed Functional Metalloenzyme  that Reduces O2 to H2O with over a Thousand Turnovers” (Miner,K. D., 
Mukherjee, A., Gao, Y.-G., Null, E. L., Petrik I. D., Zhao, X., Yeung, N., , Robinson, H., and Lu, Y.) 
2.1  Introduction 
2.1.1 Rationale for protein design 
Protein enzymes drive nearly all biological functions, catalyzing a wide range of 
reactions with high efficiency. Many of the enzymes involved in the most important and 
interesting processes for life, such as photosynthesis and respiration, are quite complex, making 
the fine details of their function difficult to study, understand, and mimic in artificial systems. 
Therefore, it is a grand challenge to rationally design smaller and more robust artificial enzymes 
with catalytic sites and activities similar to those native enzymes. To meet this challenge, we 
must test and expand our current knowledge of the working of enzymes to design enzymes 
capable of use in biotechnological applications. Toward this goal, great progress has been made 
in designing proteins with structures similar to native enzymes1-7 and advances in computational 
biology have allowed for rational design of function as well8-14. Despite these achievements, 
most designed enzymes have relatively simple active site structures and low activities with 
limited turnovers. Designing artificial enzymes with more complexity and higher turnovers will 
advance this field and decrease the likelihood that background reactivity or experimental artifacts 
would be mistaken for enzymatic reactivity. Building enzymes from the ground up will reveal 
structural features responsible for tuning enzymes and facilitate incorporation of artificial 
enzymes into practical applications. Here, we report the rational design of a functional model of 
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heme-copper oxidase (HCO), a metalloenzyme with a heterogeneous binuclear metal center that 
catalyzes the reduction of oxygen to water. Our model enzyme can actively reduce oxygen to 
water with over 1000 turnovers. By constructing this model enzyme from the bottom up we have 
gained insight into some of the critical structural features involved in native HCO respiration 
activity. Insights gained from further studies of such a designed enzyme may lead to alternatives 
to precious metal catalysts in fuel cells. 
Heme-copper oxidases represent an ultimate test of our ability to design complex proteins 
with important functions. As the terminal oxidases in aerobic respiration, HCOs catalyze the 
reduction of oxygen to water while transferring the free energy of this reduction into a proton 
gradient for the production of ATP, a universal energy source for most biological processes15-17. 
This reduction reaction is a difficult part of the aerobic respiration process and is also crucial to 
alternative energy production via fuel cells. While many catalysts that reduce oxygen to water 
have been reported18-21, a long-standing challenge is to carry out the reaction without the 
production of reactive oxygen species (ROS), such as superoxide and peroxide. ROS not only 
damage biomolecules in cells and components in fuel cells, but also decrease energy efficiency 
as ROS are a result of incomplete catalysis. In addition, efficient catalysts using non-precious 
metal ions such as iron or copper will greatly decrease costs in practical applications22,23.  
The active site of HCO responsible for such an important reaction is a complex 
heterogeneous bimetallic center containing a His-ligated heme center coupled to a copper center 
(called CuB) that is coordinated by three His residues, one of which is cross-linked to a Tyr 
residue (Figure 1A). Despite numerous studies, the exact structural features of HCO responsible 
for efficient oxygen reduction, such as the role of the metal ion in the CuB site and that of the 
tyrosine next to the copper coordinating His, are not well understood24-27. The gap in the 
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understanding of this enzyme is a direct result of HCOs being large membrane proteins, with 
molecular weights of ~200,000 Da., making it difficult to prepare homogeneous protein in large 
amounts. In addition, HCOs contain multiple metal-binding sites, making it difficult to study a 
single site without interference from the other sites. These complications prevent the use of 
HCOs in practical applications, despite being highly efficient catalysts under mild conditions. 
While much effort has been devoted to preparing synthetic models to overcome these 
limitations18,19, very few model systems are capable of actively reducing oxygen to water with 
multiple turnovers and without releasing ROS20,28. Furthermore, because synthetic models are 
prepared using small organic molecules in organic solvents, it is difficult to introduce long-
range, non-covalent interactions such as those between the conserved tyrosine and water 
molecules and their associated hydrogen bonding networks, which have been shown to be 
important for HCO function. 
As an alternative to studying native enzymes or purely synthetic molecules, we chose to 
use a small, stable, easy to produce and well-characterized protein to design an oxygen reduction 
enzyme that could mimic HCOs2. Myoglobin (Mb) is an ideal choice, as it is much smaller than 
HCOs, (17kDa) and easier to prepare and crystallize than both native HCOs and their synthetic 
model complexes. As a heme protein without other metal-binding sites, Mb has been a model 
heme protein for many spectroscopic studies and thus has often been used to calibrate 
spectroscopic signatures of heme proteins.  
2.1.2 Review of myoglobin and selected CuBMb oxygen chemistry 
 Sperm whale Myoglobin (swMb) has been extensively studied for many decades29. Under 
reducing conditions at or near physiological pH, swMb has been observed to undergo 
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autoxidation, i.e. the conversion of ferrous oxygen bound myoglobin (OxyMb) to the water 
coordinated ferric iron myoglobin (MetMb) form with the release of superoxide30. This rate 
increases as the pH is decreased from pH 8 to pH 6 due to an increase in protonation of the 
bound oxygen which is released as superoxide. The rate of autoxidation can also be enhanced by 
the presence of copper31. The introduction of two histidine residues into the heme pocket of 
myoglobin at positions 29 and 43 (L29H and F43H) resulted in the formation of a copper binding 
site in myoglobin ligated by the two introduced histidines and the naturally occurring distal 
histidine (His 64), forming a CuB site similar to that in Cytochome c Oxidase CcO32, a type of 
HCO (Figure 2.1). This myoglobin mutant, called CuBMb, displays copper dependent 
degradation of the heme cofactor into verdoheme (heme oxygenase activity), which is not 
observed in wild-type swMb32,33. This result is noteworthy in that CcO oxidase activity, the 
active site chemistry that we are modeling, shares some intermediates with heme oxygenase 
activity. 
 
Figure 2.1 Comparison of (A) bovine CcO heme-CuB site (PDB 1V54), (B) Heme pocket of WTswMb (PDB 1JP6) 
and (C) Heme pocket of CuBMb. 
 
 
A B C
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2.2 Materials and methods 
All chemicals, unless otherwise specified, were obtained from Sigma (St. Louis, MO) or Fisher 
Scientific (Hampton, NH). 
2.2.1 Purification of proteins 
The F33Y and G65Y mutations were introduced as previously described32 and confirmed 
by DNA sequencing at the Biotechnology Center of the University of Illinois. F33Y CuBMb and 
G65Y CuBMb were purified using a protocol previously described11 from inclusion bodies with 
a yield of ~20 mg/L with the following changes: R/Z (an estimate of protein purity with higher 
R/Z representing a purer protein preparation) was calculated using A408/A280 for F33Y CuBMb, 
and A410/A280 for G65Y CuBMb. Proteins with R/Z values of 3.5 or greater for G65Y CuBMb 
and 4 or greater for CuBMb and F33Y CuBMb were used in these studies. CuBMb was purified 
as previously described32 using a modified protocol for WTswMb. 
2.2.2 Crystallization of F33Y CuBMb 
F33Y CuBMb (1.0 mM) in 100 mM Tris base pH 8, (pH adjusted H2SO4), was mixed 1:3 with 
well buffer (0.1 M sodium cacodylate, 0.2 M sodium acetate trihydrate and 30% w/v 
polyethylene glycol 8000) using the hanging drop method with 300 µL well buffer in the well of 
the crystallization tray. 
2.2.3 Diffraction data collection 
The crystals were first soaked briefly in cryoprotectant (30 % polyethylene glycol 400) and were 
flash frozen in liquid nitrogen. The diffraction data sets summarized in Table S1 were collected 
at the National Synchrotron Light Source beamline X12C (Upton, NY) and were processed with 
HKL2000 software34. 
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2.2.4 Crystal structure determination 
The crystal structure was solved by the molecular replacement method using MOLREP in the 
CCP4 Package35. Refinement was performed using X-plor36 and SHELX’9737. For the crystal 
structure of CuBMb, the positions of H43 and H29 were rebuilt using the program O38. For the 
structure of F33Y CuBMb, the position of Y33 was rebuilt using the program O 38. All crystal 
structure determinations were performed by Mr. Yi-Gui Gao, of the George L. Clark X-Ray 
Facility and 3M Materials Laboratory, University of Illinois at Urbana-Champaign, as part of a 
collaboration. 
2.2.5 Computer modeling of proteins 
Computer models for F33Y CuBMb and G65Y CuBMb were created using Visual Molecular 
Dynamics39 (VMD) and NAMD40 (Molecular Dynamics Simulator) as described previously11 
with the following changes: the CuBMb structure was used as the starting structure upon which 
computer modeling simulations were performed on and the non-heme metals were not 
introduced into the simulation.  
2.2.6 17O Nuclear magnetic resonance (NMR) spectroscopy 
1H Decoupled 17O NMR spectra were collected at 81.3 MHz on a Varian UNITY INOVA 
spectrometer with a 5 mm AutoTuneX probe. Temperature was held constant at 25 °C by an FTS 
Systems unit. Gradient shimming was performed and the water signal was referenced to 0 ppm. 
Samples were placed inside an Omni-Fit NMR tube from Wilmad LabGlass (Vineland, NJ). 17O 
labeled (phenol-17O 35 %) L-tyrosine (~ 380 mM in water) was sealed inside of a capillary and 
placed inside the Omni-Fit (gas tight) NMR tube, serving as an external standard against which 
the H217O signal could be monitored. An external standard was used instead of an internal 
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standard due to the high pH requirement for solubility as well as eliminating any possible 
interference in the reaction. The L-tyrosine concentration used allowed detection in a matter of 
minutes and overcame the small volume of the capillary as well as 35% labeling of L-tyrosine. 
N,N,N′,N′-Tetramethyl-p-phenylenediamine dihydrochloride (TMPD) and ascorbic acid were 
added to a protein solution of either F33Y CuBMb, G65Y CuBMb, or WtswMb resulting in a 500 
µL volume sample at a concentration of 50 µM protein, 5 mM TMPD and 50 mM ascorbic acid 
in 50 mM potassium phosphate, pH 6. Immediately after TMPD and ascorbic acid addition, an 
initial spectrum collected over a period of ten minutes, followed by removal from the instrument, 
injection of 1 mL 17O2 at roughly atmospheric pressure (Cambridge Isotope Laboratories, Inc., 
Andover, MA, 70.7 % oxygen-17 content) into the Omni-Fit NMR tube, sealing of the port, 
inversion for 15 seconds to aid in oxygen saturation of the solution, and subsequent data 
collection. During data collection the tube was spun at 10Hz to aid in mixing. Time points were 
collected as appropriate. In between each time point the tube was removed from the instrument, 
inverted for 15 seconds, and replaced. Data were analyzed using MestReNova (Mestrelab 
Research, Santiago de Compostela, Spain).  The area of the tyrosine signal was set to 1 for all 
spectra and the area of the water signal was recorded in relation to this value. Collection of 17O 
NMR spectra was performed with the assistance of Dr. Eric L. Null. 
2.2.7 UV-visible spectroscopy  
All UV-visible spectra were acquired with an Agilent 8453 spectrometer (Agilent Technologies, 
Santa Clara, CA) using the supplied Chemstation software and kinetics package. Ferric protein 
spectra were obtained by taking 2 mL of 6 µM protein as isolated. For deoxy protein spectra, 
excess sodium dithionite was added, for unambiguous assignment. For oxy protein spectra, the 
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protein was reduced using ascorbic acid (1000 eq) and TMPD (100 eq) and oxygen was bubbled 
into the solution to ensure a clean oxygen-bound spectrum. 
For kinetic spectra monitoring of the reduced protein, the spectrum of the ferric (oxidized) form 
was collected first as a comparison using 2 mL of 6 µM protein in air-saturated 50 mM 
potassium phosphate pH 6 containing 2.2 µM catalase in a cuvette. The cuvette was sealed with 
a septum, wrapped with parafilm, and allowed to stir under an argon headspace. Then ascorbic 
acid (1000 eq) and TMPD (100 eq) were added to reduce the protein and spectra were collected 
over a period of 60 minutes. 
For determination of heme degradation rate, 4 mL of 18 uM protein was reduced using ascorbic 
acid (1000 eq) and TMPD (100 eq) in 50 mM potassium phosphate pH 6 in the absence or 
presence of up to 2 eq CuSO4 and with or without 2.2 µM catalase. After addition of reductant, 
the cuvette was capped to minimize oxygen from the air diffusing into solution. As both heme 
degradation and water production contributes to oxygen consumption, the rate of heme 
degradation was subtracted from the observed rates of oxygen consumption in the presence of 
copper to determine the total rate of water production (the activity that we are interested in 
modeling).  
2.2.8 Oxygen consumption rate and turnover studies using an oxygen electrode  
The reduction of myoglobin so that it may bing to oxygen requires a reductant to convert the 
oxidized metMb to a form able to bind oxygen. This is a required step in reduction of oxygen to 
water. Our reductant and mediator ascorbic acid (1000 eq) and TMPD (100 eq), respectively, 
were added to 500 µL of 18 µM protein in air saturated 50 mM potassium phosphate pH 6. We 
choose to study the protein at pH 6 because we found that the enzymatic activity is higher at 
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lower pH values, likely due to the greater availability of protons, which can play a significant 
role in O2 reduction to water. Consumption of oxygen was monitored using either an oxygen 
electrode (Oxytherm System, Hansatech Instruments Ltd., Norfolk, England) with data collected 
every 0.1 seconds or a YSI Model 53 oxygen meter equipped with a water-jacketed and stirred-
glass measuring vessel (1.8 mL volume) with data collected every 0.6 seconds. Oxygen 
consumption rates were calculated by taking the derivative of the oxygen concentration using a 
30 s data window (300 points or 50 points). For data where catalase and SOD, (Superoxide 
Dismutase) (Enzo Life Sciences International, Inc., Plymouth Meeting, PA), were used, 2.2 µM 
and 250 units (as defined by manufacturer) were added, respectively, before addition of 
reductant. The reaction of catalase and SOD with hydrogen peroxide and superoxide, 
respectively should produce one equivalent of oxygen per two equivalents of the respective 
ROS41,42 This is important as the production of ROS and water both consume oxygen. By being 
able to determine how much ROS are produced we can use that rate to calculate the amount of 
water, if any produced. The maximum initial rate of oxygen consumption measured was reported 
after subtraction of a background rate of oxygen consumption caused from added reductant and 
mediator alone reacting with oxygen.  
Studies to determine the maximal number of turnovers related to oxygen consumption the model 
protein can perform, i.e. multiple turnover studies were performed with the same starting 
conditions as the rate oxygen consumption rate studies above, except that the starting oxygen 
concentration was ~500 µM (~28 eq). Reductant was added and oxygen consumption was 
monitored until all oxygen was consumed. After the consumption of all oxygen, approximately 
500 µM oxygen in solution was reestablished by was introduced oxygen gas into the head space 
of sealed chamber. This process was repeated until no more turnovers were observed. Turnovers 
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performed during oxygen addition were not used in the calculation of overall activity. After 
every 4 cycles, ascorbic acid (~330 eq) and TMPD (~33 eq) was added to compensate for 
consumed reductant. 
2.2.9 ICP-MS studies 
 ICP-MS samples for WTswMb, CuBMb, F33Y CuBMb, and G65Y CuBMb were 
prepared by exchanging, the as purified the protein into 50 mM Bis-Tris pH 7 and diluting to a 
concentration of 100 µM. Samples were assayed by the microanalysis facility at the University 
of Illinois for the presence of Fe, S, Zn, Ag, Cu.   
2.3 Results and discussion 
2.3.1 Design of tyrosine containing CuBMb mutants 
In an attempt to more closely model the active site of native CcO, a tyrosine was 
introduced in proximity of the CuB site of CuBMb to mimic the His-Tyr crosslink in the native 
system and to study the effects of introducing a tyrosine into the model system (see Chapter 4 for 
efforts in introducing the His-Tyr crosslink).  
 In designing F33Y CuBMb, the sequences of A and B type CcOs were considered. In 
these CcOs, the crosslinked His-Tyr are four residues apart, i.e. His 240 is linked to Tyr 244 in 
an alpha helical structure. The corresponding locations in CuBMb for a tyrosine are residues 25 
and 33 for linkage to His 29, residues 39 and 47 for linkage to His 43, and residues 60 and 68 for 
linkage to His 64. Many of these locations are too far from the heme iron to be viable locations 
based on the CuBMb crystal structure (e.g. residues 25, 60, 47)  or may potentially interfere with 
heme binding or oxygen chemistry, residues 39 (based on computer simulations). Therefore, 
residue 33 was considered the best location. With regard to steric considerations, the mutation of 
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the native phenylalanine at position 33 to a histidine should be fairly conservative. See Figure 
2.2 for an overlay of the computer model and crystal structure of F33Y CuBMb. The high level 
of agreement between the model and structure provides confirmation of our modeling 
techniques. For reference, an overlay of bovine CcO and F33Y CuBMb has also been included. 
Although the CuBMb His residues overlay well with the bovine CcO structure43 (PDB: 1V54) 
the positioning of the tyrosines do not overlay well. 
  
Figure 2.2 Comparision of a 1.9 angstrom Met F33Y CuBMb crystal structure (cyan) with (A) F33Y CuBMb 
computer model (yellow) and (B) Crystal structure of bovine CcO (1V54) (grey). Note: the waters in the F33Y 
CuBMb structure have been omitted for clarity. 
 The design of G65Y CuBMb was influenced by two factors. First, the three dimensional 
structure of bovine CcO was used as a basis for positioning of the Tyr-OH–heme Fe distance. 
Secondly, because all the possible His-Tyr positions based on A- and B-type CcOs had been 
considered in the design of F33Y CuBMb, a design that more closely mimicked the C-type CcOs 
was attempted44. C-type CcOs have crosslinked His-Tyr residues on separate alpha helicies. This 
allowed for other locations not previously considered to be evaluated.  Based on energy 
minimized molecular dynamics simulations, the G65Y CuBMb Tyr-OH is positioned 
approximately 5.6 angstoms from the Fe atom of the heme which is nearly identical to the 
distance in Bovine CcO43,45. The relative positioning of the Tyr-OH is also supported by the first 
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reported structure of a C-type CcO46, which was published after G65Y CuBMb was designed. An 
overlay of the computer model of G65Y CuBMb and Pseudomonas stutzeri CcO (Ps CcO) can be 
seen in Figure 2.3. The positioning of tyrosine hydroxyl in the model and the Pseudomonas 
stutzeri CcO relative to the heme is in good agreement. 
   
Figure 2.3 (A) Energy minimized computer model of G65Y CuBMb and (B) Overlay of the crystal structure of cbb3 
HCO from Pseudomonas stutzeri (tan) and G65Y CuBMb computer model (yellow). 
2.3.2 Myoglobin, CuBMb, F33Y CuBMb, and G65Y CuBMb oxygen chemistry at pH 6  
It should be noted that the CuBMb proteins are purified do not contain a metal in the CuB site as 
confirmed by ICP-MS (see Table 2.1). The work described in this section is without metal added. 
2.3.2.1 UV-visible spectroscopy 
 Myoglobin is well studied and the oxidized (MetMb), reduced (DeoxyMb), and oxygen 
bound (OxyMb) states are well known29. Figure 2.4 contains reference UV-visible spectra of 
WTswMb, F33Y CuBMb, and G65Y CuBMb. The oxidized form of G65Y CuBMb has a 
significant bis-His ligated population, where the distal His64 is ligated to heme iron.  
Interestingly, the oxygen bound forms of the CuBMb tyrosine derivatives have blue-shifted Soret 
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bands at ~411 nm, versus a Soret band of ~418 nm for WTswMb, suggesting that the 
introduction of a tyrosine residue perturbs the environment of the heme pocket. 
Comparing the UV-visible traces of the three proteins under reducing conditions, 
WtswMb quickly forms OxyMb as expected and displays a fairly stable OxyMb spectrum even 
after reaction for one hour. Both tyrosine containing mutants also quickly formed OxyMb. 
However, unlike WtswMb, a population of DeoxyMb was also detected for the tyrosine mutants, 
which increased as the reaction proceeded. This suggests that enough oxygen is being consumed 
by the proteins to preclude oxygen binding, leading to the formation of DeoxyMb. CuBMb also 
displays this activity but it is much slower than the tyrosine mutants. This activity is different 
than what was observed by Sigman et al.32 where the OxyMb Soret at 418 nm was fairly stable 
without metal added. 
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Figure 2.4 Reference UV-visible spectra and time-dependent spectra, respectively of the reaction of 6 µM of 
WTswMb (A-B), F33Y CuBMb (C-D), and G65Y CuBMb (E-F) under reducing conditions at pH6. Reactions were 
monitored for one hour to ensure that the reaction was complete. Note: ‘Ferric’ is used in the reference as G65Y 
CuBMb contains a population of bis-His myoglobin in the oxidized state. 
2.3.2.2 Oxygen electrode studies 
Oxygen electrode studies were performed to assay both the product and relative rates of 
protein oxygen consumption. In these studies, we observed a rate of oxygen consumption for all 
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four proteins (Figure 2.5). The activity observed for WTswMb is surprising given that UV-vis 
studies show only oxygen binding capability. However, differences in the amount of protein used 
and difficulty in completely preventing leaking of air into the cuvette during the UV-visible 
studies could explain lack of observed activity by UV-visible work. In fact WtswMb is expected 
to have an increased rate of autoxidation30, i.e. the release of superoxide from OxyMb and the 
formation of MetMb, under mildly acidic conditions. This increase is caused by a higher rate of 
protonation of the bound oxygen compared to more basic conditions. This expected autoxidation 
rate explains the activity (i.e. oxygen consumption) observed with WTswMb in the sealed 
chamber of the oxygen electrode. The main products of WTswMb oxygen consumption in the 
oxygen electrode are reactive oxygen species, based on control studies where the rate of apparent 
oxygen consumption by WTswMb slows in the presence catalase. Similar results were also 
obtained in the presence of both SOD and catalase. Therefore based on the activity of catalase 
and SOD to convert reactive oxygen species back to oxygen, which caused the apparent slower 
rate, the product is a ROS. The similarity between the conditions with catalase only and with 
both SOD and catalase results, indicates hydrogen peroxide is the ROS produced. The source of 
the species in solution, hydrogen peroxide, is autoxidation. The product of autoxidation, 
superoxide, is unstable under the  slightly acidic (i.e. pH 6) and reductive conditions of the 
assay47 and forms hydrogen peroxide.  The amount of rate change caused by the addition of 
catalase and SOD can be used to calculate the rate of water production as half of the ROS is 
converted by these enzymes back to oxygen. The maximal decrease in observed oxygen 
consumption rate possible by SOD and catalase, if no other processes are occurring, and all the 
product is ROS is half the oxygen consumption rate observed in the absence of SOD and 
catalase. Therefore, if the apparent oxygen consumption rate in the presence of SOD and catalase 
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is greater than half the oxygen consumption rate in the absence of SOD and catalasesome water 
must be formed assuming no other processes are interfering, such as verdoheme formation. 
CuBMb has a slower overall rate of oxygen consumption than WTswMb but the 
percentage of water produced, as opposed to ROS species, is greater based on a smaller 
percentage change in the apparent oxygen consumption rate in the presence of catalase and SOD 
for CuBMb compared to WtswMb,  (See Figure 2.5C). This is probably because the reduction of 
oxygen to water has many more steps than the release of a partially reduced intermediate. It 
should be noted that the calculated rate of water production in CuBMb is approximately equal to 
that of WTswMb. Therefore, CuBMb is either lacking the hydrogen bonding network to deliver 
protons to the bound oxygen or the ability to reduce the oxygen effectively. Considering the 
reactions are carried out with excess reductant, there should be enough electrons or reducing 
equivalents available for the complete reduction of oxygen to water. If instead, CuBMb was 
unable to provide an environment where the initial reduction of the oxygen was more favorable 
than WtswMb, results similar to  WTswMb would be expected because protonation of the bound 
oxygen, the alternative under these conditions, would cause autoxidation because the protonated 
oxygen leaves a neutral superoxide30.   
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Figure 2.5 – Oxygen consumption data for WtswMb, CuBMb, F33Y CuBMb, and G65Y CuBMb at pH 6. (A) 
Representative oxygen consumption traces in the absence of SOD and catalase. (B) Oxygen consumption rates in the 
presence or absence of catalase or catalase/SOD. (C) Calculated rates of water and peroxide/superoxide production 
in the presence or absence of 1eq Zn, Ag, or Cu and absence of catalase or catalase/SOD. (D) Multiple turnover data 
for G65Y CuBMb and F33Y CuBMb. 
The substitution of a tyrosine at position 33 in F33Y CuBMb results in an approximately 
3-fold increase in rate of oxygen consumption over that of CuBMb, with a comparable ratio of 
water to ROS produced based on the comparable percentage rate decrease in the presence of 
catalase and SOD. The rate of oxygen consumption of F33Y CuBMb is about 1.5 times faster 
than that of WTswMb with a considerably higher percentage of water production in F33Y 
CuBMb compared to WtswMb (see Figure 2.5C). This is based on the lower percent change of 
apparent oxygen consumption rate in F33Y CuBMb change with catalase and SOD (see Figure 
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2.5B), compared to WTswMb. The increase in the rate of water production, compared to CuBMb 
(see Figure 2.5C), could be due to a better hydrogen bonding network in F33Y CuBMb since the 
hydroxyl group on the tyrosine which is not present in CuBMb could potentially stabilize a 
bound water molecule. With a Tyr-OH to heme iron distance of ~8Å, it is unlikely that Tyr33 is 
directly interacting with the bound oxygen directly and must be communicating through a water 
molecule. The Met F33Y CuBMb structure does not contain a water (see Figure 2.6B) within 
hydrogen bonding distance for F33Y CuBMb to interact through.  However, a reorganization of 
the water molecules present in the structure, is possible once a ligand binds. Crystal structures of 
WTswMb in the Met48 and Oxy49 forms, PDB 1JP6 and 1MBO, respectively (see Figure 2.6), 
suggest that such a rearrangement is possible. A potential location for stabilization of a water 
molecule is near Tyr33 and His43 is possible due to potential hydrogen bonding partners.  In 
addition, a crystal structure of F33Y CuBMb with a side-on bound, putatively assigned as peroxo 
species, bound to the heme iron has been obtained, as discussed  later in Chapter 5, this structure 
has a different positioning of water molecules in the heme pocket, and this distribution of waters 
contains one which is within hydrogen bonding distance of Tyr33. 
  
Figure 2.6 Potential rearrangement of waters after ligand binding. (A) Crystal structures of WtswMb in the Met 
(grey) and Oxy forms (Cyan) and (B) Suggested rearrangement for F33Y-CuBMb based on Met structure. 
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G65Y CuBMb has a faster rate of oxygen consumption compared to CuBMb and F33Y 
CuBMb by 9- and 3-fold, respectively (see Figure 2.5B).  Along with the increase in oxygen 
consumption there is a comparable ratio of water to ROS production (see Figure 2.5C). The 
relative position of the tyrosine in G65Y CuBMb may be more favorable for creating a hydrogen 
bonding network that promotes the reduction of oxygen to water. Considering that Tyr65 was 
designed to more closely mimic the position of the native CcO His-Tyr crosslink with respect to 
the position of the heme (Figure 2.3), this explanation seems reasonable. Since an actual His-Tyr 
crosslink is not present in the G65Y CuBMb system, it is unlikely that Tyr65 could aid in oxygen 
reduction by donating a proton to the reaction, as the pKa of Tyr (without a cross-link) is around 
10. To confirm that the heme was involved in the observed activity, oxygen consumption 
reactions for G65Y CuBMb and F33Y CuBMb were repeated in the presence of 18 mM cyanide, 
as an inhibitor of oxygen chemistry at the heme iron, with significantly decreased oxygen 
consumption activity (see Figure 2.7). 
 
Figure 2. 7  Effect of cyanide addition on oxygen consumption rate for F33Y CuBMb and G65Y CuBMb.  
To test the limits of the designed proteins, we performed multiple turnover reactions, i.e. 
reactions where the protein was allowed to consume oxygen until it was depleted, as above, and 
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then, additional oxygen was added until the oxygen consumption activity of the enzyme had 
slowed greatly. To a solution containing F33Y CuBMb or G65Y CuBMb and excess reductant, 
~500 µM or ~28 equivalents O2 was added, and oxygen reduction was monitored using an 
oxygen electrode until all oxygen was consumed. After complete consumption, a further addition 
of ~28 equivalents of O2 was carried out and oxygen reduction was measured again until all the 
oxygen was reduced. These stepwise additions resulted in the multiple plateaus observed in the 
traces for both proteins (Figure 2.5) with F33Y CuBMb reaching 505 turnovers and 
G65YCuBMb achieving 1056 turnovers (Figure 2.5D, inset). The number of turnovers reported 
here is an underestimate since the extra turnovers occurring during oxygen addition were not 
included in the calculation. These results demonstrate that the designed proteins are capable of 
hundreds of turnovers; with G65Y CuBMb exhibiting more than 1000 turnovers. 
2.3.2.3 17O NMR characterization 
To confirm that F33Y CuBMb and G65Y CuBMb are indeed reducing oxygen to water as 
designed, a more direct assay than oxygen consumption (via oxygen electrode studies) is 
required. Therefore, 17O NMR was used to identify the product of oxygen consumption by these 
proteins. By injecting 17O2 into the headspace of an NMR tube containing WTswMb, F33Y 
CuBMb or G65Y CuBMb, the production of H217O above the natural abundance of H217O in 
water, as produced by protein oxygen reduction, could be monitored. A typical 17O NMR 
spectrum, shown in Figure 2.8, consists of a peak assignable to H217O (referenced to 0 ppm) and 
a second small peak at 150 ppm assignable to 17O-labeled Tyr, which was added as an external 
standard to assist quantification. The normalized ratio of the H217O peak area and that of the 17O-
Tyr peak at 30, 60, 90, and 120 min are shown in Figure 2.7B. Consistent with UV-vis studies, 
the normalized ratio of WTswMb remains the same as that of the natural abundance of H217O in 
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water, suggesting that the protein did not produce any new H217O. In contrast, F33Y CuBMb and 
G65Y CuBMb produced up to 10 mM H217O at 120 min, as indicated by an increase in the 
normalized ratio between H217O and 17O Tyr to 1.5. These results confirm that water is indeed a 
product of F33Y CuBMb and G65Y CuBMb oxygen reduction, moreover,  the designed protein 
is performing HCO-like chemistry.  
  
Figure 2. 8 17O NMR spectroscopy.  (A) Typical background spectrum observed.  (B) Normalized change in the 
ratio of the 17O labeled Tyrosine and 17O water  peak areas over time. 
2.3.3 Effect of different metal ions on activity 
CuBMb and the tyrosine containing variants were purified from E. coli cells using a protocol that 
includes dialysis against buffer with 30 mM EDTA11,32 intended to remove metals that may have 
bound to the CuB site during purification. The effectiveness of this metal removal can be seen by 
the ICP-MS data of purified CuBMb, F33Y CuBMb, and G65YCuBMb (Table 2.1). This means 
that the oxygen reduction activity described above is in the absence of metal in the designed 
metal binding site (i.e. CuB site of CuBMb and its variants). These results are significant since 
the HCOs are purified with a Cu loaded in the CuB site. It should be made clear that HCOs with 
CuB site mutations or copper chaperone knock out mutants have much lower activity, indicating 
the importance of the metal in the CuB site to CcO activity in vivo. In the CuBMb proteins metal 
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must be added after purification otherwise the site is occupied by a water molecule. See Figure 
2.6B for F33Y CuBMb with water in the CuB site. Therefore to observe the effect of metal ions 
in the site they must be added. 
Table 2.1 ICP-MS results for levels of Ag, Cu, Fe, S, and Zn in as purified protein 
  
Note: All samples were normalized to 5.60 ppm Fe for clearer comparison 
 
As seen in Figure 2.5C, addition of 1 eq of Ag(I) or Zn(II) has no effect on the activity 
(within error for any of the proteins assayed). This is not completely unexpected as Ag(I) and 
Zn(II) are redox inactive and cannot donate an electron to the bound oxygen. The addition of 1 
eq of Cu(II) under reductive conditions yields an interesting but unexpected result. The addition 
of copper to CuBMb and F33YCuBMb results in an increase in the rate of oxygen consumption, 
which can be seen with larger length of the red and blue bars together, as these two rates sum to 
the overall rate (Figure 2.5C). However, after further experiments in the presence of catalase and 
superoxide dismutase, the rate increase appears to be from increased reactive oxygen species 
formation and not increased water production (red bars in Figure 2.5C). For G65Y CuBMb, the 
rate oxygen consumption actually slows slightly upon copper addition. This result suggests that 
the protein is becoming deactivated or not binding copper. To confirm that the tyrosine-
containing mutants could bind copper, metal binding titrations to determine dissociation 
constants, Kd,  values for copper were performed (Figure 2.9).  For F33Y CuBMb and G65Y 
CuBMb, the Kd was determined to be 2 µM and 100 µM, respectively. As a result, we performed 
studies with up to 2 eq of copper for CuBMb and its tyrosine variants to increase the percentage 
of CuB sites occupied. As seen in Figure 2.9C, the rate of oxygen consumption does increase 
Sample ppm Cu ppm Fe ppm S ppm Ag ppm Zn Ratio Cu:Fe Ratio Ag:Fe Ratio Zn:Fe
CuBMb 0.00 5.60 8.67 0.01 0.04 0.00 0.00 0.01
F33Y CuBMb 0.00 5.60 10.76 0.00 0.04 0.00 0.00 0.01
G65Y CuBMb 0.00 5.60 9.37 0.00 0.03 0.00 0.00 0.00
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with increasing copper concentration for CuBMb and F33Y CuBMb. However, in the presence of 
SOD, catalase and copper, the rate of oxygen consumption observed is slow, suggesting a high 
level of hydrogen peroxide formation either by the enzyme or by free copper. G65Y CuBMb 
showed a decrease in the rate of oxygen consumption with copper compared to rates with no 
metal.  This result is possibly due to increased copper-dependent heme oxygenase activity, which 
would inactivate G65Y CuBMb, was observed for CuBMb in a previous studies33,50, as the 
presence of 2 eq of Cu resulted in a visibly greenish solution, consistent with the formation of 
verdoheme, the product of heme oxygenase activity. To adjust for this activity an UV-vis based 
assay was performed by adapting an assay performed in previous work50 on CuBMb for copper-
dependent verdoheme formation. A UV-Vis based assay was performed using the pH 6 reaction 
conditions and verdoheme rates were measured (see Table 2.2).  The addition of Cu(II) under 
reaction conditions induces formation of verdoheme in all three proteins. The raw oxygen 
consumption rate data was then corrected using the rate of verdoheme formation obtained for the 
assay to reflect this information (see Figure 2.9D). The resulting corrected oxygen consumption 
rates obtained in the presence and absence of catalase and SOD still corresponded to high levels 
of hydrogen peroxide formation. Unfortunately, no copper containing assay condition attempted 
improved water production. However the observation of copper dependent verdoheme formation 
does suggest that copper is indeed binding.  
Table 2.2 Verdoheme formation rates (s-1) in the absence or presence of catalase and SOD 
Rates of verdoheme formation per second for CuBMb, F33Y CuBMb and G65Y CuBMb. Error indicated is Standard 
Deviation from the mean. 
 
Reagents Added
+ 1 eq Cu 8.47E-03 +/- 3.79E-04 3.77E-03 +/- 1.30E-04 8.83E-03 +/- 1.00E-03
+ 2 eq Cu 1.90E-02 +/- 8.12E-04 7.91E-03 +/- 4.54E-04 1.95E-02 +/- 7.90E-04
+ 1eq Cu, Catalase, SOD 3.38E-03 +/- 4.09E-04 2.07E-03 +/- 8.69E-05 1.98E-03 +/- 1.17E-04
+ 2eq Cu, Catalase, SOD 8.67E-03 +/- 1.24E-03 5.78E-03 +/- 4.91E-04 2.58E-03 +/- 3.22E-04
G65Y CuBMbF33Y CuBMbCuBMb
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Figure 2. 9 Determination of copper affinity and effect of copper dependent verdoheme formation.. Copper Kd 
determination for oxidized (A) F33Y CuBMb and (B) G65Y CuBMb in bis-Tris HCl  pH 7. Observed oxygen 
consumption rates with up to 2 eq Cu for CuBMb, F33Y CuBMb, and G65Y CuBMb (C) with and (D) without 
correction for verdoheme formation.  
 
2.4 Summary and Conclusions 
 CuBMb and its tyrosine containing variants perform HCO like chemistry, even in the 
absence of copper in the engineered CuB site. This result is unexpected as HCOs are generally 
isolated with copper in the CuB site and are inactive if mutations are made that interfere with Cu 
binding. This suggests that copper is not required for this type of chemistry to occur and that the 
role of the copper in the CuB site in HCOs may only be to increase the activity of the native 
system up to physiologically required levels, as we have shown that our system can perform the 
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required chemistry without the copper but a levels much lower than HCOs. Electrons used by our 
proteins are supplied via the addition of excess reductant that either reduces the heme and/or 
ligand to the heme. The CuBMb system appears to be unable to fully utilize copper for CcO 
chemistry as demonstrated by the observed verdoheme activity and the lack of an increase in 
HCO-like activity upon binding of copper to CuBMb and its tyrosine containing variants. Despite 
this shortcoming, the oxygen consumption rate of G65Y CuBMb is only 300-fold below that of 
some HCOs. As copper has been shown to provide an electron to reduce bound oxygen in CcOs, 
there are two likely causes of the proteins described here to produce water at a higher rate with 
copper. The first possibility is our system is unable to utilize the copper due to being unable to 
transfer electrons in and out of the CuB copper. This may be plausible as antiferromagnetic 
coupling of the copper in the CuB site and heme iron in our system requires a ligand bound to the 
heme iron such as cyanide to be observed as shown previously32. The absence of  
antiferromagnetic coupling without a ligand implys poor communication between the sites, and 
as a result the copper may not be becoming reduced before the oxygen binds and therefore does 
not have an electron to donate to the reduction of oxygen to water. An alternate possibility is that 
proton delivery is limiting, and that without efficient delivery of protons the enzyme has a rate 
limiting step of proton delivery that prevents rapid rate increase with copper. Such a proton 
delivery problem may be indicated the observed copper-dependent heme oxygenase activity,  
which is a result of a presumably  increased population of the ferric hydroperoxo species (cpd 0) 
that is common to both HCO and heme oxygenase chemistries without the formation of cpd I, 
which would have resulted from efficient proton delivery to cpd 0 . To resolve this a more 
extensive hydrogen bonding network or an efficient  source of protons analogous to proton 
channels of HCOs might be required. The resolution of these issues will make the CuBMb 
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system more efficient and more specific (less ROS production), making the system more ideally 
suited for practical applications. As described here, as a first generation model, this system could 
potentially be used in practical applications if one can prevent catalyst deactivation (likely due to 
catalyst poisoning by ROS production) after ~1000 turnovers. Described in the following chapter 
are early attempts at resolving these issues by using native HCOs and knowledge gained from 
previous studies with our system as a guide.   
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CHAPTER 3 
EFFECT OF ADJUSTING HYDROGEN BONDING NETWORKS ON OBSERVED 
OXYGEN CHEMISTRY 
3.1 Introduction 
3.1.1 Role of hydrogen bonding networks 
 The secondary coordination environments of proteins can have a significant effect on 
activity in a given active site. For instance, hydrogen bonding networks can modulate the activity 
of proteins by affecting the pKa values of amino acid side chains or allowing transfer of protons 
to substrates In heme proteins it has been postulated that one of the key differences between 
heme oxygenases1,2, that use oxygen to degrade heme, and heme proteins that cleave the 
dioxygen bond, such as heme copper oxidases (HCOs)3,4 that convert oxygen to water is the 
extensiveness of the hydrogen bonding network around the bound oxygen5 and thus the ability to 
donate protons to it. The delivery of protons to the heme-CuB site in HCOs must be efficient in 
order to maintain the proton gradient6,7 used to produce ATP and to sustain efficient reduction of 
oxygen to water. The transfer of protons in HCOs is mediated by proton channels3,8, namely the 
so called D and K channels, which supply protons to the Heme-CuB site for reduction of oxygen 
to water, as well as for translocation across the membrane, in the case of the D-channel. Many 
studies have been devoted to elucidating the function of these proton channels9-11. The water 
molecules in K-channel hydrogen bond to the hydroxyl group of the a/o-type heme in the heme-
CuB site and to the hydroxyl of the His-Tyr crosslinked residues4,12.  
The CuBMb and F33Y CuBMb and G65Y CuBMb work presented in Chapter 2 showed 
that the tyrosine-containing mutants of CuBMb could produce water from molecular oxygen and 
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that the rate varied with positioning of the introduced tyrosine. The fastest mutant described, 
G65Y CuBMb, had a rate of oxygen consumption that is approximately 300-fold slower than 
some HCOs. However, in the work above there were no proton channels designed to deliver 
protons to the Heme-CuB site, nor was there a heme that contained a hydroxyl group analogous 
to the hydroxyl group of hydroxyfarnesyl substituent of the a/o-type hemes. In an effort to study 
the effects of these features in CuBMb and its tyrosine containing mutants, a non-natural heme 
cofactor and a hydrophilic channel were introduced, separately into each mutant.  
3.1.2 Advantages of introducing a proton channel over further reduced pH 
Considering that lowering the pH from 8 to 6 allowed for discovery of the oxygen 
activity of this system, it might be expected that a further lowering of the pH of the bulk solution 
might further improve the activity observed. While this suggestion is logical, the stability of 
myoglobin in acidic conditions is limited as pH decreases13,14. Also, further decrease of pH will 
likely increase the rate of autoxidation that produces ROS15, and with His residues being our 
likely proton source, the  probability of significantly increasing population of protonated His is 
low. Therefore, further introduction of mutations to mimic proton channels to increase proton 
access to the site is a more attractive but technically more difficult alternative. If achieved it 
would make our model system more like HCOs. However, the locations need to be chosen 
carefully, as a high number of mutations or highly destabilizing mutations may be as problematic 
as lowering the pH. 
3.1.3 Summary of previous work with CuBMb containing a mimic of heme o 
 Our other proposed route to improve the activity of CuBMb and  tyrosine-containing 
variants, introducing a non-natural heme cofactor with a hydroxyl group analogous to the 
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hydroxyl of a hydroxyfarnesyl group of a/o type hemes, has been performed previously for 
CuBMb16.  In the previous study, the effect of incorporating Fe(III)-2,4-(4,2)-hydroxyethyl-
vinyldeuterioporphyrin IX (referred to as heme o mimic)  on copper dependent verdroheme 
formation the CuBMb system was investigated. 2,4-(4,2)-Hydroxyethyl-vinyldeuterioporphyrin 
IX is a compound nearly identical to protoporphyrin IX (heme b) with one vinyl group replaced 
with a hydroxyethyl group (see Figure 3.1). The replacement of the native heme b of 
myoglobinwith heme o mimic in CuBMb, denoted CuBMb(o), was achieved by unfolding 
CuBMb purified with heme b (denoted CuBMb(b)) and replacing with the heme o mimic. In a 
later obtained crystal structure, a crystallographic water was observed within hydrogen bonding 
distance of the hydroxyl group of the heme o mimic in V68T CuBMb, which is not observed in 
CuBMb with the native heme b17 (see Figure 3.3 below).  
  
Figure 3.1 Comparision of heme types 
At pH 8 CuBMb displays a copper dependent heme oxygenase activity as shown by 
Sigman et al.18 To form verdoheme, an intermediate in heme oxygenase chemistry, an Fe (III)-
Heme o Heme b
Heme o mimics
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hydroperoxo intermediate, also known as compound 0 (cpd 0), is formed. This subsequently 
reacts with the alpha-meso carbon5 and begins the pathway toward verdoheme/biliverdin 
formation. However, protonation of this intermediate would result in scission of the oxygen-
oxygen bond, forming compound I (cpd I) and releasing a molecule of water. The incorporation 
of the heme o mimic leads to a 19-fold reduction in the rate of the copper dependent verdoheme 
formation at pH 816. This effect was not seen with the mesoheme cofactor that replaces the vinyl 
of heme b with an ethyl. This reduction in observed verdoheme rate can be explained by at least 
two possible effects; either the formation of the Fe (III)-hydroperoxo, (cpd 0), was slowed, thus 
inhibiting the formation of the intermediate required to form both HCO or  heme oxygenase 
chemistry or the other possibility is that the rate of HCO-like activity was increased by the 
improved hydrogen bonding network and the Fe (III)-hydroperoxo intermediate became 
protonated more efficiently. In the process of performing the work in Chapter 2 we developed an 
assay for testing HCO-like activity in the CuBMb system. The results of the assay were 
confirmed using 17O NMR and we therefore have confidence in its accuracy. This assay should 
allow us to begin to answer the question of how the heme o mimic slows verdoheme formation 
by assaying its effect on HCO-like activity. Therefore, the goals of the work below is to 
investigate the effects of altering the hydrogen bonding network in CuBMb, F33Y CuBMb, and 
G65Y CuBMb on HCO-like activity by two methods: First, incorporate the heme o mimic into 
the CuBMb and its tyrosine variants. Second, make multiple point mutations to design 
hydrophilic channels to attempt to mimic the proton channels found in HCOs. The aim of this 
approach is to provide better proton access to the heme pocket and possibly improve chemistry 
performed in the CuBMb system by increasing the rate oxygen consumption and/or ratio of water 
to ROS produced.  
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3.2  Materials and methods  
3.2.1  Protein purification 
The mutations were introduced using site directed mutagenesis using a protocol 
previously described19 and confirmed by DNA sequencing at the Biotechnology Center of the 
University of Illinois. All proteins except CuBMb were purified from inclusion bodies using a 
protocol previously described20 with a yield of ~20 mg/L. For F33Y CuBMb and variants R/Z 
was calculated using A408/A280, and for G65Y CuBMb and variants using A410/A280; for G65Y-
CuBMb, protein with an R/Z value of 3.5 was used. CuBMb was purified as previously 
described19 using a modified protocol for WTswMb. 
3.2.2  Heme o mimic preparation and incorporation into protein 
2,4-(4,2)-hydroxyethyl-vinyldeuterioporphyrin IX was obtained from Frontier Scientific. 
Iron was incorporated as previously described16. The mass of the product was confirmed via ESI-
MS. Product with less than 20% signal intensity corresponding to b-type heme or Fe-HVD-
acetate ester was used for incorporation. The yield of Fe(III)-2,4-(4,2)-hydroxyethyl-
vinyldeuterioporphyrin IX obtained was assayed by UV-Visible spectroscopy, by dissolving in 
0.066M NaOH and was diluting into acetonitrile. Yield was estimated using an ε395 of 12.4 mM-
1. Apo-protein was prepared by extracting the heme using 2-butanone as was described 
previously16. Apo-protein concentrations were determined spectroscopically using an ε280 of 30 
mM-1. Protein was diluted to ~10 µM, and typically buffered with ~10 mM potassium phosphate 
pH 7, which seemed to increase the incorporation yield. Protein was slowly incorporated with 
heme o mimic by addition of 1/6 equivalent every 15-20 min, with the protein solution on ice 
with stirring and wrapped in foil. After 1 eq had been added, a second was added by 1/3 eq 
additions every hour. Incorporation was allowed to proceed overnight.  R/Z ratios and protein 
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concentrations were measured using the Soret absorbances at 404 nm for CuBMb(o), F33Y 
CuBMb(o), and 405 nm for G65Y CuBMb(o). Soret extinction coefficients of heme b variants 
were used as estimates for the heme o forms. Please note that as G65Y CuBMb met form has not 
been characterized, therefore met F33Y CuBMb extinction coefficient was used as many CuBMb 
mutants have a similar coefficient. 
3.2.3  Computer models for hydrophilic channels 
Energy minimized computer models for H36S/F106S F33Y CuBMb (2S_F33Y CuBMb) 
and V21S/V68S/F36S G65Y CuBMb (PCM_G65Y CuBMb) were performed using Visual 
Molecular Dynamics (VMD) 21 and Scalable Molecular Dynamics (NAMD) 22 as mentioned in 
Chapter 2,with the following changes - the starting structure for 2S_F33Y CuBMb was V68T 
CuBMb(o) with the heme o mimic replaced with heme b and Thr68 reverted back to Val68. All 
necessary mutations were made in addition to these. For PCM_G65Y CuBMb, the starting 
structure was the last time point of a G65Y CuBMb molecular dynamics equilibration of 10 ps. 
Because the goal of this simulation was to see positioning of water in the heme pocket and 
designed hydrophilic channels, molecular dynamics simulations were carried out for a longer 
duration (50 ps), than those described in Chapter 2. 
3.2.4  Oxygen electrode studies 
Oxygen electrode studies were performed as described in section 2.2.8 of chapter 2. Extinction 
coefficients ε408 of 135 mM-1 and 109 mM-1 were determined for 2S_F33Y CuBMb and 
2S_G65Y CuBMb, respectively, using a hemachromagen assay. It should be noted that the water 
and ROS calculations assume that all rate reductions are purely from activity of catalase and/or 
SOD. Other factors such as copper dependent verdoheme formation may need to be corrected for 
separately.  
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3.3  Results and discussion 
3.3.1 UV-Visible characterization of heme o mimic incorporated proteins 
Consistent with previous studies16, the incorporation of the heme o mimic into CuBMb, denoted 
CuBMb(o), causes a blue shift of the metMb Soret band to 404 nm confirming that CuBMb(o) is 
formed (Figure 3.2). F33Y CuBMb and G65Y CuBMb displayed a similarly shifted Soret band 
after incorporation with heme o mimic. In the case of G65Y CuBMb(o) the Soret band at 405 nm 
was unexpected, as G65Y CuBMb with native heme b, as purified has a significant bis-his 
population, with a Soret at ~410 nm and R/Z ratio of ~3.5. G65Y CuBMb(o) refolded with an 
R/Z of ~4 which is consistent with larger population of metMb. An extinction coefficient of 175 
mM-1cm-1 was used to estimate concentrations, as many CuBMb mutants have approximately 
this value for metMb. It should be noted, refolding of G65Y CuBMb to obtain a higher 
population of met could be useful for crystallization, as no conditions have been found for 
crystallizing G65Y CuBMb as purified. 
 
Figure 3.2 UV-Visible spectra of 6uM CuBMb(o) (black), F33Y CuBMb(o)(red) and G65Y CuBMb(o) (blue). 
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3.3.2 Effect of heme o mimic on CuBMb activity 
The rationale for expecting a difference in activity using the heme o mimic stems from the 
reduction on copper-dependent verdoheme formation previously observed and the observation of 
an additional an unpublished crystal structure where V68T CuBMb(o) displayed a 
crystallographic water not observed in the CuBMb structure with heme b (see Figure 3.3A). This 
extra water appears to be within hydrogen bonding distance of both the water observed in the 
CuB site and the hydroxyl of the heme o mimic. A stabilized water in this position may help 
form a better hydrogen bonding network for activity. The presence of heme o mimic in CuBMb 
results in an increase of the rate of oxygen consumption of approximately 50% compared to 
CuBMb (see Figure 3.3B). Interestingly CuBMb(o) relative ratio of water to ROS is 
approximately the same as CuBMb, meaning that the heme o mimic enhanced the activity. The 
addition of Zn(II) and Ag(I) as redox inactive mimics has no effect on the rate of CuBMb(o) 
similar to equivalent data for CuBMb. In the case of Zn(II)-CuBMb(o) the ratio water to ROS 
produced is lower however, this result is nearly within error. Addition of Cu(II) causes an 
increase in observed rate that is likely due to an increase in ROS produced, but is also nearly 
within error. These results suggest that the metal in the site, even a redox inactive metal, is 
disrupting the chemistry observed in CuBMb(o). It is possible that the metal is disrupting an 
interaction of His43 with a water stabilized by the additional hydroxyl group, by binding to the 
CuB site and affecting the hydrogen bonding network. 
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Figure 3.3 (A) Overlay of CuBMb (cyan) and V68T CuBMb(o) (black) structures Orange spheres are water in the 
V68T CuBMb(o) structure. Arrow indicates the additional water observed. (B) Rates of water (blue) and ROS 
production in CuBMb and CuBMb(o). Arrow indicates the additional water observed.  
3.3.3 Effect of heme o mimic on F33Y CuBMb 
When compared to CuBMb, F33Y CuBMb displays a 3-fold higher rate with the native heme b in 
the heme pocket. Based on the increase just discussed with CuBMb(o), it would be reasonable to 
expect that F33Y CuBMb(o) would have a rate between those of F33Y CuBMb and G65Y 
CuBMb. The rate increase in the latter case is approximately 20%, much less than the CuBMb 
case and the ratio of water to ROS is comparable to the results obtained with F33Y CuBMb with 
the native heme b. The calculated rates of water and ROS production are within error. Even in 
the presence of metal the rates and ratios are essentially the same. It seems that there is little 
effect from heme o mimic aside from the slight rate increase. This may be rationalized by the 
suggestion of reorganized waters in the pocket with a ligand bound as discussed in the 
conclusions of Chapter 2. If the tyrosine hydroxyl is stabilizing a water molecule within 
hydrogen bonding distance of His43 as suggested with a ligand bound the heme o mimic 
hydroxyl may be hydrogen bonding to a water that exists in the heme b version of F33Y CuBMb. 
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Considering the position in the heme pocket of the hydroxyl of the structure, there may be no 
proton for the additional network to transfer and thus only a mild effect on activity. 
  
Figure 3.4 (A) Overlay of F33Y CuBMb (cyan) and V68T CuBMb(o) (black) structures (B) Rates of water (blue) 
and ROS production in with and without heme o mimic(o). Arrow indicates addition water observed. 
3.3.4 Effect of heme o mimic on G65Y CuBMb 
For G65Y CuBMb, the effect of the heme o mimic is hard to predict as the location of the 
tyrosine based on the computer model of G65Y CuBMb is relatively distant from the heme o 
hydroxyl, unlike in HCOs, and may have little effect. However, the likelihood of stabilizing a 
water near His43 could be similar to that of CuBMb and following the logic and results of the 
argument for the lack of activity increase for F33Y CuBMb, an increase like that observed in 
CuBMb might be expected in G65Y CuBMb. The rate of oxygen consumption for G65Y 
CuBMb(o) is within error of the rate for its heme b counterpart, both approximately 5.4 µM/s. 
The ratio of water to ROS is close but G65Y CuBMb(o) appears to produce more ROS compared 
with the native heme incorporated, in the presence or absence of metal, although the individual 
water and ROS production rates are very close to the level of error for most metals. For G65Y 
CuBMb with native heme b, verdoheme production in the presence of copper slows the apparent 
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rate, as described in Chapter 2. In G65Y CuBMb(o), the apparent oxygen consumption rate is 
faster in the presence of copper. The observed rates are 5.4 µM/s without copper and with 5.9 
µM/s respectively which is beyond error. The percentages of water produced is ~65% in both 
cases. This would suggest that copper enhances the rate slightly but not the product formed. As 
G65Y CuBMb(o) produces more ROS in general, this copper-enhanced rate with no effect on 
product is a step in the right direction; but excitement is tempered by the general effect of heme o 
mimic in G65Y CuBMb increasing ROS. 
 
Figure 3.5 - (A) Overlay of G65Y CuBMb model and V68T CuBMb(o) structure (B) Rates of water (blue) and ROS 
production in with and without heme o mimic. Arrow indicates addition water observed. 
3.3.5 Rationale and Design of F33Y CuBMb Channel Mutant 
In CcOs the K-channel ends near the location of the His-Tyr crosslink. The hydroxyl 
group of the hydroxyfarnesyl group of o and a type hemes is suggested to be hydrogen bonded to 
the water in the K-channel4,23. With this in mind a design for a simple hydrophilic channel that 
ended near the location of both the hydroxyethyl group of heme o mimic incorporated CuBMb 
variants based on the V68T CuBMb(o) structure, and Tyr33 in F33Y CuBMb was attempted. The 
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shortest route to bulk solvent would be by making a hole in the heme pocket wall formed by BC 
loop region and the G-helix. The closest residue to the location of the hydroxyl of the heme o 
mimic that points into the heme pocket is Thr39. Because this residue is already suitable for 
hydrogen bonding, all that may be needed are mutations to make space for water to enter into the 
back of heme pocket. Mutations introducing potential hydrogen bonding partners to stabilize 
water in the proposed channel were introduced, namely F106S and H36S. F106S was selected as 
alternative to mutations in literature that are known to destabilize myoglobin24, specifically 
Y103X, while still making space in the desired region of the protein. H36S was selected becuase 
it is surface exposed and might potentially interact with Glu38, which could block our channel. 
Simulations were performed to test this design before attempting to express the designed protein. 
To simulate potential extra water in the heme pocket of myoglobin as a result of the new 
channel, the above crystal structure of V68T CuBMb with heme o mimic was used because it has 
three crystallographic waters compared to the two of F33Y CuBMb. To this starting structure the 
T68V/F33Y mutations were made in addition to the hydrophilic channel mutations. The resulting 
molecular dynamics equilibrated model can be seen in Figure 3.6. Interestingly the serine 
hydroxyl groups appear to hydrogen bonding to a water from the bulk solvent occupying part of 
the space generated by the F106S mutation. This simulation also suggested that methyl group of 
Thr39 might be blocking access of water to the heme pocket. Therefore two mutants of F33Y 
CuBMb were made, H36S/F106S/F33Y CuBMb and H36S/T39S/F106S CuBMb (referred to as 
2S_F33Y CuBMb 3S_F33Y CuBMb respectively). 
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Figure 3.6 Molecular Dynamics simulation results for 2S_F33Y CuBMb. Proposed channel residues are shown in 
Tan.  
3.3.6 Effect of hydrophilic channel mutations on F33Y CuBMb 
Both 2S_F33Y CuBMb and 3S_F33Y CuBMb mutants were able to reduce oxygen using TMPD 
and ascorbate similar to F33Y CuBMb. The observed oxygen consumption rates of these new 
mutants were approximately twice that of F33Y CuBMb, with approximately the same ratio of 
water to ROS produced (see Figure 3.7A). The 2S_F33Y CuBMb mutant was found to be more 
stable than 3S_F33Y CuBMb and was obtained at a higher yield, and was therefore used for 
more thorough characterization of the channel. The addition of metals to 2S_F33Y CuBMb had a 
similar effect to what was observed in F33Y CuBMb (See figure 3.7B). This would suggest that 
the introduction of mutations designed to allow bulk solvent better access for the purpose of 
enhancing the existing hydrogen bonding network was a success.  
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Figure 3.7 – Rates of water and ROS production for (A) F33Y CuBMb and the 2S and 3S variants and (B) F33Y 
CuBMb and 2S_F33Y CuBMb in the presence and absence of 1eq Zn, Ag, and Cu.  
3.3.7 Rationale and Design of G65Y CuBMb Channel Mutants 
In designing a proton channel mutant for G65Y CuBMb to deliver protons near the introduced 
tyrosine, we chose not to immediately use the above mutations designed for F33Y CuBMb, 
because Tyr65 is located on the opposite side of the heme pocket from residue 33. We also 
decided against simply making a hole in the nearest wall, as it was likely that the exposed heme 
edge would become larger or that the interaction between the porphryin and hydrophobic 
residues would be disrupted by mutation to hydrophilic residues. These effects could make 
interpretation difficult. We therefore decided to engineer a channel into the hydrophobic core of 
myoglobin that would emerge into the heme pocket near Tyr65. This channel design consisted of 
3 mutations to G65Y CuBMb. Val 21, Val68, and Leu69 were mutated to serine residues. 
Computer simulation of this mutant was performed using the G65Y CuBMb simulation results as 
a starting point and then introducing the 3 mutations (See Figure 3.8). Val21 is surface exposed 
and should pose minimal problems. Val68 has been mutated to both Thr and Ser in the literature 
and myoglobin was able to fold. Leu69 is the residue most likely to pose a problem to folding as 
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it is in the myoglobin core and is surrounded by hydrophobic residues. However, the space 
generated by this mutation could allow for a water to be trapped and hopefully stabilized by 
hydrogen bonds to the introduced serines or the backbones of nearby residues. Also, as further 
investigation of the effect of the H36S/F106S mutations introduced into F33Y CuBMb. These 
mutations were introduced into G65Y CuBMb for comparison (referred to as 2S_G65Y CuBMb). 
 
Figure 3.8 Molecular Dynamics simulation results for PCM_G65Y CuBMb. Proposed channel residues are shown 
in Tan.  
 
3.3.8 Effect of Channel Mutations on G65Y CuBMb 
 The effect of the introduction of the three serine residues designed to create PCM_G65Y 
CuBMb on activity is still yet to be determined, as the protein as isolated had low yield due to 
protein instability. The portion that was recovered was folded into a bis-His state that would not 
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readily reduce with TMPD and ascorbate. However, heme extraction and refolding of this mutant 
may yield more of a metMb-like population, as was observed for G65Y CuBMb with heme o 
mimic, and potentially avoid this issue. These difficulties lead to characterization of 2S_G65Y 
CuBMb to see the general effect of these mutations. 
 The results of the introducing the F106/H36S mutations into G65Y CuBMb (2S_G65Y 
CuBMb) is different than that of 2S_F33Y CuBMb. This is not completely unexpected becuase 
the mutations are on the other side of the heme pocket from Tyr65. Instead of increasing the rate 
of oxygen consumption as in 2S_F33Y CuBMb, 2S_G65Y CuBMb actually has an 
approximately 30% slower rate, compared to G65Y CuBMb. While initially this would seem like 
a setback, reactions in the presence of catalase and SOD had nearly no effect on the oxygen 
consumption rate observed. This would suggest that the product formed in 2S_G65Y CuBMb is 
exclusively water, within error of our methodology (see Figure 3.9). The rates of oxygen 
consumption toward water are comparable for both G65Y CuBMb and 2S_G65Y CuBMb. This 
may be because the hydrogen bonding network in 2S_G65Y CuBMb could be hydrogen bonding 
from multiple sides of the bound oxygen or the introduced hydrogen bonding could adjusting the 
pKa of His43 allow it to transfer protons more effectively. Either of these could alter the rate of 
proton donation to the bound oxygen and allowing for a more rapid transfer to the bound oxygen. 
The introduction of redox inactive metals into the site had little effect on the oxygen 
consumption rate but the apparent level of ROS production is higher. In the case of copper the 
observed rate is slower without catalase and therefore our assumptions in calculation of water 
and ROS fail (see red bar in the water direction in Figure 3.8) this would suggest that ROS are 
being consumed which is not the case. This failure is likely the result of copper-induced 
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verdoheme formation. As rates of verdoheme formation have not been determined for this 
mutant, G65Y’s rates were used as an estimate to obtain an estimate of water to ROS ratios.  
 
Figure 3.9 – Water (blue) and ROS (red) production rates for G65Y CuBMb and 2S_G65Y CuBMb in the absence 
and presence of 1eq of Zn, Ag, and Cu. The red bar in the water side of graph suggesting ROS consumption is 
breakdown of our assumptions. Asterisk indicates correction using G65Y CuBMb verdoheme rates 
3.4 Summary and Conclusions 
 The effects of trying to alter the hydrogen bonding network in CuBMb and its tyrosine 
variants shown to perform HCO like chemistry are interesting. The incorporation of heme o 
mimic into the CuBMb, F33Y CuBMb and G65Y CuBMb had a different result in each mutant. 
For CuBMb the overall rate increased by 50% without metal and the ratio of products was 
essentially unchanged. With metal the percent ROS increased slightly. For F33Y CuBMb there 
was essentially no change, which seems to be consistent with the hypothesis that a water may be 
stabilized by Tyr33 in the oxygen bound state which would likely not allow heme o mimic 
enough space to have another water molecule. For G65Y CuBMb the inclusion of the cofactor 
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caused a small general increase in the percent ROS formed. However, copper-loaded G65Y 
CuBMb(o) kept the same product ratio and slightly increased overall rate. This is in contrast to 
G65Y CuBMb with native heme b which is slowed by Cu addition, likely from verdoheme 
formation. The addition of hydrophilic channels with the goal of increasing the access of protons 
into heme pocket has been shown to have two different effects; the first effect is a rate increase if 
the channel added is from the same side of the heme pocket as the tyrosine as in 2S_F33Y 
CuBMb, but little change in the ratio of products formed. This effect might an indication of better 
flow of protons into the same hydrogen bonding network. The other observed effect is 
potentially both more important and more interesting. This second effect occurs when the 
channel introduced is on the opposite side of the pocket from the introduced tyrosine residue as 
in 2S_G65Y CuBMb. The rate of the oxygen consumption decreases but the products formed 
have a higher percentage of water, in the case of metal free 2S_G65Y CuBMb nearly 100% 
conversion to water from oxygen. This cleaner catalyst should be more robust in terms of total 
turnovers, as the production of ROS is believed to be the downfall of G65Y CuBMb causing a 
significant slowing after about 850 turnovers. Design of a proton channel on the same side as the 
introduce tyrosine G65Y CuBMb was performed, in the PCM_G65Y-CuBMb mutant, but the 
resulting protein was difficult to purify and characterize. The combination of the heme o mimic 
and 2S hydrophilic channel in G65Y CuBMb has the potential be a very interesting protein. The 
resulting 2S_G65Y CuBMb(o) could potentially be very clean and not be degraded as quickly in 
the presence of copper. The heme o hydroxyl would be well positioned to interact with both the 
hydrophilic channel and waters in the heme pocket, potentially improving the effect of the 
channel further.  
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CHAPTER 4 
PROGRESS TOWARD HIS-TYR CROSSLINK FORMATION IN CUBMB 
MUTANTS WITH TYROSINE 
4.1 Introduction 
 The purpose of the work described herein is to improve the CuBMb1,2 model of heme 
copper oxidases (HCOs) by introducing a His-Tyr crosslink and then comparing the activity of 
uncrosslinked tyrosine-containing CuBMb with that of the crosslinked version, in a fashion 
similar to the work described in the preceding chapters. Such a study would allow for a direct 
comparison of the crosslinked His-Tyr with the same His and Tyr uncrosslinked in the same 
protein environment. Such work has yet to be reported in HCOs. 
4.1.1 Brief overview of crosslinked posttranslational modifications 
 Posttranslational modifications such as phosphorylation, glycosylation, and ubiquination 
are common is living systems3. These modifications can extend the functionality of proteins 
beyond that of the 20 amino acids or hold two sections of a protein in close proximity by 
covalent linkage4. Modifications can range in size from a linkage of 2 amino acids, e.g. disulfide 
bonds, to addition of sugars, to the attachment of whole proteins such as ubiquination3. The 
function of these modifications can also vary: Some are structural in nature and lock the protein 
into a given conformation, others are involved in signaling; for example ubiquination is well 
known to signal for degradation. Many enzymes in the cell either modify other enzymes or are 
modified themselves by other enzymes; e.g. the kinases involved in signaling pathways. Some 
amino acid linkages are proposed to be mediated by nearby metal cofactors, such as the recently 
reported Phe-Val crosslink in protein 4. This result in particular is interesting because it is 
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relatively difficult to form radicals at both of the involved amino acid side chains. The novel His-
Tyr crosslink of HCOs is also thought to result from the early turnovers at the heme-CuB site5.  
4.1.2 Summary of His-Tyr Crosslink features and proposed roles 
 The His-Tyr crosslink is a unique structural feature found in all HCOs. This structural 
feature was first identified using X-ray crystallography6,7 and was confirmed via Mass 
Spectrometry and Edman Degradation5. Mutation of the crosslinked Tyr residue to Phe8 causes 
loss of copper in the CuB site and abolishes enzyme function. Unfortunately, HCOs have not 
been isolated lacking the His-Tyr crosslink unless mutation of the crosslinked residues had been 
performed. This makes study of function in the native system difficult, as changes needed to 
remove the crosslink change more than the crosslink itself. Small molecule analogs of the 
crosslinked His-Tyr amino acids have been made to study the effects of this covalent bond on the 
properties compared to His and Tyr9-11. Similar analogs have been incorporated into synthetic 
models of HCOs12-14. The proposed function of the crosslink ranges from merely structural15 to 
the donation of a proton and/or an electron to the reduction of oxygen to water16. The pKa of the 
hydroxyl of the crosslinked His-Tyr was ~3 pKa units below that of Tyr. This would make the 
pKa of the His-Tyr linkage ~7. Under physiological conditions such a residue should be able to 
donate a proton and therefore could be expected to be a source of protons for the reduction of 
oxygen to water. 
4.1.3 Rationale for inclusion in CuBMb system and unique benefits 
As part of the process of constructing a functional bottom-up model of CcO from 
myoglobin an effort has been made to incorporate this unique and important feature. How the 
His-Tyr crosslink is formed in HCOs is unknown but it is believed to be formed during the early 
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turnovers of the enzyme5. Therefore, our experiments, if successful, may provide new insight 
into the mechanism of formation of this feature in the native enzyme and what relative 
positioning of the two components relative to each other may be required. The experimental 
design involves reaction of the Tyr-containing CuBMb mutant with either oxidant (such as 
H2O2), copper alone, reductant alone, or copper with reductant. Ideally, we would prefer 
formation via reductant or reductant with copper for a more physiologically relevant result. The 
sections below summarize the progress made toward incorporating a His-Tyr crosslink into the 
CuBMb system and note observed side reactions. 
4.2 Materials and methods 
4.2.1 Protein purification 
 All tyrosine containing mutants and variants described in this chapter are purified from 
inclusion bodies using a previously described protocol.17 Typical yields from the inclusion body 
protocol are ~20 mg/L. I28Y and F33Y CuBMbs and variants purify in the metMb form and the 
purified protein is evaluated for quality by taking the ratio of A408/A280 and if the R/Z value is 4 
or greater the protein is consider usable. For G65Y CuBMb the ratio of A410/A280 is used and the 
protein with a value of ~3.5 is used. The lower cutoff is a result of a population of bis-His ligated 
protein that is present in this mutant; as bis-His has a lower extinction coefficient than the met 
form. As discussed in Chapter 2 this purification protocol results in protein that does not contain 
metal in the CuBMb site based on Inductively Coupled Plasma-Mass Spectrometry (ICP-MS) 
results.  
4.2.2 Crosslinking experiments 
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Unless otherwise noted all buffer solutions were treated with Chelex 100 beads (Sigma) 
to remove divalent metal ions. 
To check for crosslinking under reaction conditions 1 mL of 50 µM protein was reacted in a 1.5 
mL eppendorf tube with stirring and with the appropriate reagents for 30 minutes at room 
temperature. Reactions at pH 8 and pH 6 used 20 mM tris-HCl and 100 mM potassium 
phosphate , respectively. In reactions with catalase, enzyme was added in levels consistent with 
work by Sigman et al.2 Reactions were stopped by running the reaction mixture down a PD-10 
column equilibrated with either water or 20 mM Tris-HCl, pH 8. Colored eluent was collected. 
Two different methods were used to remove the heme cofactor before digestion with the 
appropriate protease. The first method used was analytical High Pressure Liquid 
Chromatography (HPLC) using a C18 column after concentrating the reaction products to a 
volume of ~100 µL. This instrument used was a Waters Delta 600 with Waters 600 controller 
and Waters 2487 Dual λ detector. The reaction was injected onto a pre-equilibrated Vydac 
218TP54 C18 column. The column was equilibrated using 84% solvent A and 16% solvent B 
where solvent A is 0.05% TFA in distilled H2O (dH2O) and solvent B is60 % acetonitrile 
(ACN), 0.05 % trifluoroacetic acid (TFA) in dH2O. The percentage of Buffer B was ramped up 
to 83% over the first 20 minutes then ramped up to 100% over the next 2 minutes, and then held 
for eight minutes to clean the column (30 minutes overall). Over the next 2 minutes buffer B was 
lowered to 16% (84% A) and then held for the remainder of the run (13 minutes) to equilibrate 
the column. The whole procedure lasted 45 min per sample. Absorbances at A280 and A380 were 
used to monitor protein and free heme respectively. Any heme signal associated with the protein 
was presumed to be covalently attached. The protein containing fractions were pooled, flash 
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frozen, and lyophilized overnight. The lyophilized protein was resuspended in the buffer needed 
for the protease used. 
  The second method used was extraction of the heme using 2-butanone. For this method 
the protein was exchanged in to water. The protein was then unfolded using 1% v/v of 2 M HCl 
and to this an equal volume of ice cold water saturated with 2-butanone was added and then the 
mixture was mixed by inversion. The butanone layer (top) should be red from free heme. The 
bottom layer should be colorless, if not additional HCl was added and mixed again. If still 
colored then there is likely covalently attached heme. In reaction conditions known to form 
verdoheme, a greenish color was observed. The top layer was removed by Pasteur pipet and 
replaced with fresh 2-butanone until top layer was colorless. To remove the 2-butanone dialysis 
against water was performed until 2 exchanges after the 2-butanone was no longer smelt, 
typically 5 to 6 dialysis steps. The final exchange was against the buffer used for protease digest. 
4.2.3 Digestion of proteins with proteases after removal of the heme 
The heme-free protein was digested by either 20 µL of 1 µg/µL Salt Free α-
Chymotrypsin (Sigma) in 100 mM Tris-HCl, pH 7.8 for I28Y CuBMb or by 20 µL of 1 µg/µL 
Proteomics Grade Trypsin (Sigma) in 1 mM HCl added to protein in 230 µL of 100 mM 
ammonium bicarbonate, pH 8.5 for all others. Crude digest mixtures were then either analyzed 
using MALDI-MS or injected onto an HPLC column for further purification. 
4.2.4 Isolation of crosslinked peptide by HPLC 
After digestion of protein the resulting crude digestion mixture was purified by HPLC to 
isolate the potentially crosslinked fragment. Crude digestion mixture in the amount of 100 µL 
was injected onto a pre-equilibrated Vydac 218TP54 C18 column. The column was equilibrated 
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90% solvent A and 10% solvent B where solvent A was 0.05% TFA in dH2O and solvent B was 
100% ACN, 0.05% TFA in dH2O. The method was run at 1 mL/min and starting conditions of 
10% B were held for 10 minutes. The percentage of Buffer B was ramped up to 60% over the 
first 120 minutes and then ramped up to 100% to wash the column for 30 minutes, and then re-
equilibrated over 40 minutes. Absorbances at A225 and A315 were monitored (A225 for peptide 
backbone and A315 for possible crosslink specific signal) The resulting peaks were then run on 
MALDI-MS (Matrix Assisted Laser Desorption Ionization Mass Spectometery) to determine the 
mass of the peptide(s) in the peak. 
4.2.5 UV-Vis characterization of isolated peptide 
Specrta were collected using a Cary 3E spectrophotometer (Varian). The isolated 
potentially crosslinked fragment was dissolved in modified universal buffer (50 mM sodium 
acetate, 40 mM MES, 40 mM MOPS, 40 mM Tris, 40 mM CAPS, 100 mM potassium 
phosphate). The 100 mM sodium nitrate normally used was replaced with 100 mM potassium 
chloride to avoid absorbance from the nitrate interfering with the monitoring of changes in the 
UV region. To adjust the pH 2 M HCl was added. The pH values listed were measured by adding 
a given amount of HCl to buffer before adding the peptide fragment. The same amount was 
added to buffer containing either isolated potentially crosslinked peptide or a control peptide 
ordered with the appropriate sequence based on MALDI-MS results. 
4.2.6 MALDI-MS 
 MALDI-MS , using a Voyager DE, as performed on either the crude digestion product or 
fractions collected after HPLC using a C18 column. The matrix used was α-cyano-4-
hydroxycinnamic acid. The accelerating voltage was 20000 V, the mass range was 400 – 4000 
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Da, and the low mass gate was set to 400 Da. Laser intensity varied from 1800 – 2200 depending 
on sample. An insulin/angiotensin mixture was used as a standard for calibration. Crude digest 
samples could typically be seen with usable intensity with a 1:10 ratio of sample-to-matrix 
solution. HPLC purified peptide samples could be seen typically with a 1:5 dilution. All expected 
values were based on the use of the Protein Prospector tool ( prospector.ucsf.edu).  
4.2.7 LC-ESI-MS/MS 
Crude digest samples were also submitted for LC-ESI-MS/MS (Liquid Chromatography 
– Electrospray tandem Mass Spectometry and the liquid chromatography step was performed 
using the same protocol and column used for the HPLC purification for consistent peak elution 
times for comparison purposes. The LC-MS/MS samples were run by the Mass Spectrometry 
facility at the University of Illinois at Urbana-Champaign. 
4.3 Results and Discussion 
Please note that all observed crosslinking masses obtained using MALDI-MS are 
hydrogen peroxide-dependent unless stated. 
4.3.1 I28Y CuBMb  
Considering the positioning of the three His residues that form the CuB site in CuBMb, 
covalent attachment between Tyr28 and His29 seems the most reasonable based on 3-
dimensional location (see Figure 4.1). For I28Y, CuBMb chymotrypsin protease was used. 
Chymotrypsin cleaves primarily after Trp, Tyr, Phe, and Leu (with lower frequency) residues. 
Based on the sequence of I28Y CuBMb this should produce a His containing peptide with a mass 
of 686 Da and a Tyr containing peptide of mass 1460 Da and crosslinking of the two would give 
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a mass of 2142 Da. See Figure 4.2 for the I28Y sequence with potential cleavage points noted by 
arrows and Table 4.1 for a list of expected and observed masses by MALDI-MS. 
 
Figure 4. 1 Molecular dynamics simulation results for I28Y CuBMb.  
I28Y CuBMb did not display a mass corresponding to the crosslinked peptides of interest. 
This result is not unexpected as residues to be crosslinked are adjacent residues in an alpha helix. 
The distance between the His nitrogen and the nearest Tyr carbon that would give the 
appropriate crosslink are 4.2 angstroms based on computer modeling results. However, there is a 
peak with a mass that is 4 Da less than the expected crosslinking mass and that is hydrogen 
peroxide dependent (See Table 4.1). 
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Figure 4.2 Potential cleavage sites for A) chymotryptic digest of I28Y CuBMb, tryptic digest of B) F33Y CuBMb, 
and C) G65Y CuBMb. Intended His and Tyr for crosslinking are colored red. The smallest possible Tyr containing 
peptide is shown in green. For F33Y CuBMb grey sequence is Tyr containing peptide if Lys34 cleavage is missed 
The smallest possible His containing peptide is shown in blue. 
4.3.2 F33Y CuBMb 
 The protease used for F33Y CuBMb was trypsin. Trypsin cleaves after Arg and Lys 
residues. As seen in Figure 4.2 the F33Y Sequence has a cleavage site in between the His and 
Tyr and shortly after the Tyr. Based on the sequence of F33Y CuBMb this should produce a His 
containing peptide with a mass of 1617 Da, Tyr containing peptides of masses 423 Da and 1345 
Da (depending on cleavage after Lys 34), and crosslinking of the two peptides would give 
masses of 2040 Da and 2961 Da. See Figure 4.2 for F33Y CuBMb sequence with potential 
cleavage points noted by arrows and Table 4.1 for other masses of interest.  
 
 
 
L HVW AKVEADVAGHGQDY HIRL F KSHPETLEKHDRF KHLK
I28Y CuBMb
F33Y CuBMb
LHVWAK VEADVAGHGQDIHIR LYK SHPETLEK HDRFK HLK
LHVWAK VEADVAGHGQDIHIR LFK SHPETLEK HDRFK HLK 
TEAEMK  ASEDLK K HYVTVLTALGAILK K K
G65Y CuBMb
A
B
C
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Table 4.1 Expected and observed digested protein fragments for His 29 Tyr 33 crosslinking 
 
4.3.2.1 Studying the isolated crosslinked peptide 
 F33Y CuBMb, like I28Y CuBMb, forms a new mass upon reaction with hydrogen 
peroxide. The mass observed by MALDI-MS is 1-2 Da more than calculated which is within 
error of the MALDI-MS. The mass observed would require amino acids 17-42 to be present in 
the crosslinked peptide (see Table 4.1). The most plausible interpretation would be that a 
covalent bond involving Tyr 33 is formed that prevents the cleavage of the peptide backbone 
after Arg 31 or Lys34. The peptide of interest was isolated by HPLC from a crude trypsin digest 
mixture. See Figure 4.3 for an overlay of the HPLC traces of the tryptic digests for F33Y CuBMb 
+ H2O2 and unreacted F33Y CuBMb and the corresponding MALDI-MS spectra. In the inset of 
I28Y CuBMb 29 - 33 HIRLF 685 686
All non-I28Y CuBMb 17 - 31 VEADVAGHGQDIHIR 1617.7 1618
I28Y CuBMb 15 - 28 AKVEADVAGHGQDY 1460 1459
F33Y CuBMb 32 - 42 LYKSHPETLEK 1345.5 N. A.
L32V/F33Y CuBMb 32 - 42 VYKSHPETLEK 1331.5 N. A
L32V/F33Y/T39A 32 - 42 VYKSHPEALEK 1301.5 N. A.
L32V/F33Y/L40A 32 - 42 VYKSHPETAEK 1289.5 N. A.
G65Y CuBMb 64 - 78 HYVTVLGAILK 1499.8 1500
L32V/F33Y/T39A CuBMb 17- 42 XL VEADVAGHGQDIHIR  + 
VYKSHPEALEK
2917.2 2936
L32V/F33Y/L40A 17- 42 XL VEADVAGHGQDIHIR  + 
VYKSHPETAEK
2905.2 2923
G65Y CuBMb 17 - 31 , 64 - 78 XL
VEADVAGHGQDIHIR  + 
HYVTVLGAILK 3115.5 N.A.
Protein Residues Sequence
His containing peptide
Tyr containing peptide
L32V/F33Y CuBMb 17- 42 XL 2947.2VEADVAGHGQDIHIR  + 
VYKSHPETLEK
I28Y CuBMb 15 - 28 XL 2142
F33Y CuBMb 17- 42 XL 2961.2
AKVEADVAGHGQDY + HIRLF
VEADVAGHGQDIHIR  + 
LYKSHPETLEK
2964
2963
2138
Expected 
Mass
Observed 
Mass
Crosslinked peptide
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Figure 4.3A a small peak in the H2O2 reacted sample can be seen; this peak has a mass of 2963 
Da when isolated and MALDI-MS is performed (see Figure 4.4).  
  
 
Figure 4.3 Overlay of (A) HPLC traces and (B) MALDI-MS spectra of tryptic digests of F33Y CuBMb with (red) 
and without reaction with H2O2 (black). Boxed region indicates region in the inset of (A). Crosslinked peak 
indicated by arrow with observed mass by MALDI-MS. Masses listed in (B) in are colored with respect to spectrum 
referred to. Only masses of interest or masses at 100% intensity for both spectra are labelled. 
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Figure 4. 4 MALDI-MS spectrum of Isolated F33Y “Crosslinked” peptide The peaks observed correspond to the +1 
and +2 charged states of the peptide. 
Peptide sequencing using Edman Degradation on the isolated peptide resulted in the 
readout shown in Figure 4.5. This sequence reads as if there are two N-termini similar to 
observations with unreduced disulfide linked peptides18. Based on the MALDI-MS spectrum of 
the isolated peptide where neither of the masses corresponding to the individual peptides are 
observed, the only plausible interpretation is a covalent bond between a residue before Lys 34 
and a residue after Lys34. The backbone must be cleaved after Lys34 otherwise there would be 
no “2nd N-terminus”. The presence of the residues after Lys34 in the sequence requires the 
covalent bond otherwise the MALDI-MS results would not show one species. This interpretation 
suggests that the introduced tyrosine could be forming a covalent bond with a sidechain or 
backbone atom with a residue between 35 and 42 (Figure 4.5). In addition, there is no evidence 
for cleavage of the backbone at Arg 21, otherwise the first cycle of Edman Degradation would 
have indicated V, S, and L indicating a 3rd N-terminus. Therefore there is interference with 
trypsin cleavage at this site.  
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Figure 4.5 Edman degradation results and the effect on the expected peptide. The red line in the table represents the 
expected missed signal. Arrows represent trypsin cleavage.  
UV-Visible data on the isolated peptide showed a pH-dependent shift in the UV-Visible 
region peak (Figure 4.6) similar to those observed with crosslinked synthetic His-Tyr model 
compounds10. Based on controls using a synthesized peptide with the same primary sequence this 
shift was not observed. These results taken together suggest that there is indeed a covalent 
attachment formed by Tyr33 and another location in F33Y however it seems unlikely the 
attachment is with His29 as intended. 
 
 
Cycle # AA identified
1 V, S
2 -
3 E , H
4 A , P
5 D , E
6 V , T
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9 H , K
10 G , k
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16 -
17 -
18 -
VEADVAGHGQDIHIR    LYKSHPETLEK
Expected F33Y CuBMb Crosslinked peptide based on MALDI-MS
Interpretation after Edman Deg. Data
VEADVAGHGQDIHIRLYK         SHPETLEK
?
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Figure 4.6 UV-Visible changes with (A) control and (B) “crosslinked” peptide with pH change. Note: selected pH 
values displayed for B for clarity 
4.3.2.2 Work done using mutants of F33Y CuBMb  
Mutations were made to F33Y CuBMb for two reasons. The first was to attempt to 
increase the likelihood of a His-Tyr crosslink as the best conditions using hydrogen peroxide 
gave a ~15% yield based on peak area of the HPLC traces. The second reason was to discern the 
location of the covalent bond formation between Tyr33 and the peptide containing residues 35 to 
42 as based on Edman degradation UV-Vis studies on the peptide. Mutations aimed at increasing 
crosslink formation include L32V/F33Y CuBMb and Y146F/Y151F/F33Y CuBMb. An 
additional mutant, I30P/F33Y CuBMb, was purified from inclusion bodies and characterized. 
However, the protein was highly unstable and was unable to be reduced using ascorbate and 
TMPD. The L32V mutation would make CuBMb more like HCO in the region including His-Tyr 
as the conserved sequence is HPXVY in a and b type HCOs5 and F33Y CuBMb in the 
corresponding sequence is HIRLY. Studies by Wikstrom and coworkers19 observed that mutation 
of the corresponding Val to Ile caused a decrease in activity presumably from the more bulky 
residue affecting the water network in the pocket. CuBMb natively has an even more bulky Leu 
and this added bulk might interfere with crosslinking to His29. The HPLC traces of the two 
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mutants are highly similar as expected. However, the mass of the observed crosslinked peptide is 
16 Da heavier than expected. This extra mass could be either some kind of oxidative damage on 
the peptide or potentially cleavage after Arg31 as well as after Lys34. However, this situation 
seems unlikely as the tyrosine would have to form two crosslinks to amino acids on different 
helicies for this proposed species to be observed. The HPLC traces showed no significant change 
in the relative yield. The Y146F/Y151F/F33Y mutations were made based on work by Ortiz de 
Montallano’s group20 showing myoglobin dimerization via a surface Tyr151. This naturally 
occurring radical pathway would funnel radicals away from Tyr33 crosslinking and lower 
efficiency. Unfortunately, this also did not improve yield. 
 
Figure 4.7 Relative positions of potential crosslink partners for Tyr 33 
The second reason for introducing mutations was to discern the location of the covalent 
bond formation between Tyr 33 and the peptide containing residues 35 to 42 as based on Edman 
degradation UV-Vis studies on the peptide. If the identity of the amino acid Tyr is crosslinked to 
was known, we could potentially mutate it to a less reactive amino acid to avoid undesired 
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crosslinking. Point mutations replacing Thr39 and Leu40 with either Ala or Pro were made as 
these residues were closest to Tyr33 based on the crystal structure of F33Y CuBMb (see Figure 
4.7). These mutations were made in  L32V/F33Y CuBMb. For our purposes the elimination of 
the linkage should theoretically be the same for F33Y CuBMb. The intent of the Ala mutations 
was to disrupt potential crosslinks formed to a sidechain and the proline mutations where 
intended minimize the reactivity of the backbone amine at these positions. Based on MALDI-MS 
results, summarized in Table 4.1, these point mutations did not eliminate the crosslinked peptide 
as the mass in all cases shifted as expected with respect to the L32V/F33Y background. Mutation 
of His36 to Ala was also performed in order to remove the residue most likely to crosslink based 
on chemical properties of the sidechains, His36 is the only aromatic side chain aside from Phe 42 
which is too far away from Tyr33. In addition to the shifted crosslinked mass, some mutations 
displayed a new species not previously observed, with a mass corresponding to a linkage 
between Tyr33 and Tyr103, a known radical site in wild type Mb. Table 4.2 has the calculated 
masses for Tyr33 and Tyr103 linkage and the observed masses. This result is interesting in that 
we are indeed forming a radical at Tyr33 if a dityrosine linkage is formed. However, it indicates 
a low likelihood of success of obtaining a His-Tyr crosslink as desired, as both the crosslink 
between residues 35 and 42 and the dityrosine crosslink suggest that Tyr33 moves away from 
His29 instead of toward it. 
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Table 4.2 Peptide masses for observed alternate crosslinks  
 
4.3.3 G65Y CuBMb 
In an attempt to avoid the undesired covalent attachments observed in F33Y CuBMb, 
G65Y CuBMb was developed. The G65Y mutation was selected based on overlays of bovine 
CcO and CuBMb crystal structures. Computer minimization confirmed that the heme iron and 
Tyr-OH distance is ~5 angstoms. The distance based on computer modeling between Tyr65 and 
His29 is ~3.3 angstoms. (see Figure 4.8). This distance is closer than the equivalent distances in 
F33Y CuBMb. Reactions with G65Y CuBMb were performed in a similar manner to that of 
F33Y CuBMb. The expected His containing fragment is 1617 Da as in F33Y CuBMb. The 
expected Tyr containing fragment is 1500 Da. Therefore the expected crosslink mass is 3115 Da. 
It should be noted that the 1617 Da peptide mass has been observed reproducibly in F33Y 
CuBMb. For G65Y CuBMb the smallest digested fragment is flanked on both sides by at least 
one additional Lys residue. The crosslinking were to interfere with backbone cleavage by trypsin 
at the predicted locations, these flanking Lys residues would minimize the increase in the 
number of unexpected amino acids but providing additional locations to cleave the backbone.  
F33Y CuBMb 33-35 LYK 423.5 N. A.
L32V/F33Y CuBMb 33-35 VYK 407.5 N. A
L32V/F33Y/T39A 33-35 VYK 407.5 N. A.
L32V/F33Y/L40A 33-35 VYK 407.5 N. A.
L32V/F33Y/T39A CuBMb 2318 2336
L32V/F33Y/L40A 2318 2336
Potential Y33-Y103 Crosslinked peptides
Expected 
Mass
Observed 
Mass
33-35, 103-118 XL YLEFISEAIIHVLHSR + VYK
Protein Residues Sequence
Tyr33 containing peptide
Y103 Containing Peptide
All Mutants 103-118 YLEFISEAIIHVLHSR 1928 1927/1928
F33Y CuBMb 33-35, 103-118 XL YLEFISEAIIHVLHSR + LYK 2334 N/A
L32V/F33Y CuBMb 33-35, 103-118 XL YLEFISEAIIHVLHSR + VYK 2318 N/A
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Figure 4.8 Energy minimized model of G65Y CuBMb with closest His nitrogen to Tyr carbon distances labeled 
 4.3.3.1 Observed MALDI-MS and LC-ESI-MS/MS 
Reactions with H2O2 or copper with reductant did not yield any expected crosslinking 
fragments nor did MALDI-MS reproducibly give fragments corresponding to as His29-Tyr65 
crosslink. The only condition that showed a mass close to that expected was G65Y CuBMb + 2 
eq. Cu with 1000 eq. TMPD and ascorbate. This observation required a higher intensity than 
normally used on the MALDI-MS which produced a very small peak that could arguably be 
noise. To independently check for the crosslinked mass, sample was submitted for LC-ESI-
MS/MS. The same column and conditions used for HPLC peptide isolation for F33Y CuBMb 
was performed to confirm that digestion was proceeding properly and to identify the Tyr 
containing fragment and its elution time off the HPLC column. Compared to the control sample 
where only buffer was added during reaction there was significantly less of the fully digested Tyr 
containing peptide in the Cu + reductant reaction. This is interesting in that copper with reductant 
is inducing a major change to the tyrosine peptide. Unfortunately, no new Tyr containing 
fragment was observed via MS and no obvious sharp new peak was observed via LC. This may 
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be explained by the observation that crosslinked His29-Tyr65 would have a mass above 2000 
m/z and thus be outside the range of ESI-MS/MS. The peptide would have to be at least doubly 
charged to be observed. This however assumes complete digestion. If there is a missed cleavage, 
especially on the His29 peptide, the mass could be higher and require a triply charged peptide to 
be observed. However, a missed cleavage event requiring a triply charge peptide to be observed 
is less likely on the G65Y peptide as it is flanked on both sides by at least one additional Lys 
residue that could be cleaved.  
4.4 Summary, conclusions, and future experiments 
In summary, reactions of I28Y CuBMb and F33Y CuBMb formed unique peptides after 
reaction with H2O2. Based on Edman degradation and MALDI-MS, the isolated peptide for 
F33Y CuBMb does contain the portion of the protein with the His and Tyr residues for 
crosslinking. In addition, there is further support based on mutations to that portion of F33Y 
CuBMb causing the appropriate mass shifts as observed by MALDI-MS. The peptide does not 
appear to contain a His-Tyr crosslink based on Edman degradation results. However, based on 
UV-Visible studies where the pH of the solution containing the peptide isolated was adjusted 
from pH 11 to pH 3 there is a shift in the UV region similar to those observed for His-Tyr 
crosslink small molecule analogs. It is likely that this species is composed of Tyr crosslinked to 
either an amino acid side chain or backbone atom of the residues between Ser34 and Lys42. 
Based on distances from crystal structures, the most likely residues are Thr39 and Leu40 if the 
linkage is to the sidechain. This is not as unreasonable as it may seem in light of a recently 
reported Phe-Val crosslink mediated by a metal site4. However, Edman degradation should have 
given either no signal or an unknown signal for one of the residues5 if the linkage was via 
sidechain (unless the linkage was broken by the edman reaction). However, it may be more 
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likely that the linkage is to the backbone, which would not be altered by mutagenesis and would 
be more likely to be broken by the edman reaction.  
For G65Y CuBMb there was no reproducibly observed crosslinked mass using H2O2 or 
reductant in the presence or absence of copper. However, ESI-MS/MS shows significant 
differences between unreacted and protein reacted with copper and reductant. The unreacted 
trace shows a Tyr containing peak. The copper and reductant treated sample does not, nor does it 
show any new peaks that contain components of the peptide containing Tyr65. This absence is 
possibly due to poor cleavage induced by a covalent attachment and the resulting less digested 
peptide that has an m/z ratio of greater than 2000, and thus is less likely to be observed. In other 
words, if the most digested version of the peptide is produced, with a mass of 3115 Da it would 
require a charge of +2 to have an m/z less than 2000 and be observed. If a less digested peptide 
product has a mass over 4000 Da then a +3 charge would be needed, which would require a ~900 
Da mass increase. A potential source for this mass increase may be a covalent linkage to the 
heme cofactor as it has a mass of 616 Da and due to size might interfere with complete digestion. 
If the mass is less than 4000 Da such a linkage would also strongly alter the elution of the 
peptide off of the C18 column, as such a column separates by hydrophobicity and heme is very 
hydrophobic. 
To resolve these potential issues in G65Y CuBMb there are multiple routes including 
making point mutations to increase the positive charged residues that are not cleavable by 
trypsin. A related strategy is to add additional Lys or Arg residues to create smaller digest 
fragments, so that a lesser charge is needed to observe the peptide of interest. As for the covalent 
linkage with heme, a separate purification step separating the peptide peaks from the heme 
containing peaks (similar to the HPLC protocol described for heme extraction as was described 
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in the methods section) could isolate such a linkage. Subsequent direct injection into a MS 
instrument may yield confirmation of this idea. 
In the case of F33Y CuBMb, based on computer modeling of G65Y CuBMb, adding bulk 
at position 65 causes His29 to move toward Phe33. If a Phe65 mutation was made it might be 
possible to compete with the undesired linkage. However, based on Kd studies for G65Y CuBMb 
the copper binding, described in chapter 2, in this situation the likelihood of copper mediated 
linkage would be greatly reduced due to less copper binding at a given concentration of metal. 
True confirmation of any crosslinking analogous to that of HCOs will eventually require either 
Edman Degradation or crystallization to confirm any linkage. Edman Degradation was shown 
not to disrupt the linkage in HCOs by Buse et al.5 Therefore our crosslink should be able to 
withstand Edman degradation if it is the correct linkage. Crystallization would be the best way to 
confirm proper connectivity.  
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CHAPTER 5 
CHARACTERIZATION OF A NOVEL SIDE-ON BOUND OXYGEN SPECIES IN 
F33Y CUBMB 
5.1 Introduction 
5.1.1  Side-on bound oxygen in biology 
Since oxygen is diatomic, it can bind to protein in two ways: end-on, as in oxygen-bound 
myoglobin1 (OxyMb) (Figure 5.1A) and hemerythin, or side-on, as in naphthalene dioxygenase2 
(Figure 5.1B) and homoprotocatechuate 2,3 dioxygenase3. In proteins, iron-bound, side-on 
oxygen species in proteins have been observed in non-heme iron sites. Side-on oxygen species 
bound to non-heme iron are reactive species. Karlsson et al. reported crystal structures for 
naphthalene dioxygenase with the side-on bound oxygen. They proposed that this species attacks 
the napthalene substrate and produces cis-1,2-dihydrodiol. Work by Lipscomb’s lab3 reported the 
structure of ferrous iron loaded homoprotocatechuate 2,3 dioxygenase with and oxygen side-on 
bound also suggest reaction with an aromatic substrate. 
For heme proteins such as p450s, side-on bound intermediates have been proposed4; 
however, many p450s are believed to perform chemistry with the ferryl cation radical 
intermediate commonly referred to as compound I (cpdI)5. Computational work indicates that a 
side-on bound complex could not be activated to undergo dioxygen bond cleavage6. In some 
p450s, such as p450 aromatase7,8 , however, the hydrogen-bonding network in the active site 
promotes the activation of the substrate, which may suggest that proton access to the ferric 
peroxo intermediate is limited. Thus, a side-on peroxo intermediate may be the active 
intermediate. Other in p450s, such as a p450 2B47,9 mutations of the active site proton donors 
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have demonstrated an enhancement of activity, i.e. the deformylation of  
cyclohexanecarboxaldehyde,  that is thought to be performed by a side-on intermediate. 
   
Figure 5. 1  Examples of side-on and end-on bound oxygen. (A) WtswMb (PDB 1MBO) and (B) Napthalene 
Dioxygenase (PDB 1O7M). 
5.1.2 Side-on bound porphyrin complexes 
Side-on bound oxygen species have also been observed in porphyrin-based organic 
complexes. Work by Valentine and coworkers have reported observations of side-on bound 
oxygen complexes with various metals10,11, including iron10,12,13. The EPR spectra of these iron 
complexes have a signal at g = 4.2 that has been assigned to a side-on bound oxygen species. The 
side-on bound species observed were formed when porphryin complexes reacted with potassium 
superoxide in dry organic solvent. UV-visible studies for Valentine’s iron complexes were 
described as having a low-energy Soret band, and the peaks in the visible region (between 500 
nm and 700 nm) have shoulders similar to those of Ti complexes. The features of the reported 
complexes did not shift with changes in solvent or counter ion, suggesting that the complexes do 
not coordinate with them. As a result, these complexes are suggested to be six-coordinate.  This 
leaves an open coordination site to the porphyrin as the oxygen is bound in a side-on fashion. 
These complexes are sensitive to moisture and air, and they decompose rapidly. As far as 
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reactivity, the complexes are generally not electrophilic, as they do not oxidize styrene or 
cyclohexene12.  However, they have been shown to nucleophilically attack electron-poor olefins 
such as menadione to form menadione epoxide with an approximately 70% yield. The 
electrophilicity of the porphryin ring, however, does affect the ability of the complex to perform 
this chemistry. For protoporphyrin IX dimethylester (PPIXDME), an analog of the heme b in 
myoglobins, this activity does occur.  
Work by Naruta and coworkers14 in studies of porphyrin-complex-based models of HCOs 
has revealed a side-on bound peroxo species with a copper analogous to CuB in proximity. This 
complex was crystallized and will be discussed below (see Figure 5.2). Naruta and coworkers 
also recently described a seven-coordinate side-on complex that could be converted to an end-on 
ferric hydroperoxo species analogous to Cpd 0; it was produced upon protonation using 
methanol15. The additional seventh ligand, absent in side-on bound complexes mentioned above, 
was a histidine analog.  The presence of this ligand was shown to be important in the conversion 
of the side-on complex to the end-on complex. 
5.1.3 Relation to CuBMb studies 
As described in the preceding chapters, CuBMb is a model system for the study of 
HCOs16,17. The formation of a ferric hydroperoxo intermediate is an important step in the 
reduction of oxygen to water. The hydroperoxo intermediate is protonated to form (cpd I): the 
ferryl species with a cation radical. As an alternate route to cpd I, hydrogen peroxide can be 
added to ferric heme proteins via a “peroxide shunt.” A tyrosine-containing variant of CuBMb17, 
F33Y CuBMb, was reacted with hydrogen peroxide for the purpose of inducing a His-Tyr 
crosslink (described in Chapter 4). After reacting F33Y CuBMb with hydrogen peroxide, a 
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covalent bond that is not yet fully characterized formed based on mass spectrometry. When 
hydrogen peroxide reacted F33Y CuBMb was crystallized in an attempt to determine the location 
of a newly formed covalent bond. Unexpectedly, we obtained a crystal structure with a side-on 
bound oxygen species. Contained in this chapter is the first, to our knowledge, structure of a 
side-on bound oxygen species heme iron in a protein system.  Since this species is a proposed 
transient intermediate in some p450s8 and is only observed as a relatively stable species in 
organic porphyrin complexes in dry organic solvent12, there is much that could be learned by 
characterizing such a species. 
5.2 Materials and methods 
5.2.1  Purification of protein 
 The F33Y CuBMb used in this chapter was purified as described in Chapter 2. The cutoff 
ratio of A408/A280 for useable protein was 4. 
5.2.2 Crystallization of F33Y CuBMb 
Side-on bound F33Y CuBMb crystals were obtained by taking 1.7mM as purified F33Y 
CuBMb (met form) in 20 mM Tris pH 8 (pH adjusted with H2SO4).  To this protein, three eq. 
H2O2 were added and allowed to react for approximately 30 minutes. This protein was then 
concentrated using a centrifugal concentration device with a MWCO of 10 kDa. The reacted 
protein was then diluted to ~1.7 mM and mixed 2:2 with crystallization buffer (0.1 M sodium 
cacodylate, 0.2 M sodium acetate trihydrate with 30% w/v polyethylene glycol 8000) and stored 
over a well of 300 µL crystallization buffer using the hanging drop method. It should be noted 
that this method does not reproducibly result in crystals with the side-on bound oxygen species.  
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In fact, most F33Y CuBMb crystals obtained are of the met form.  The resulting protein and well 
buffer solution has a pH of approximately 7. 
Met-F33Y CuBMb crystals were also soaked with H2O2 in an attempt to reproduce the 
results of the solution crystallization described above. The crystallization of metMb has been 
described in the methods section of Chapter 2. However, the crystallization buffer used to 
produce these crystals contained 30% w/v PEG 10000 instead of 30% PEG 8000, as this was 
subsequently observed to form crystals more reliably. The crystal and mother liquor of metMb 
crystals had a volume of 4 µL. To this, 1 µL of well buffer and F33Y CuBMb in the same ratio 
(one volume 1mM F33Y CuBMb to three volumes well buffer) with 100 eq. H2O2. The 
hydrogen peroxide was added to the protein solution just prior to mixing with the well buffer. 
Mixing this solution 1:4 with the crystal drop would result in  20 eq. H2O2 compared to the total 
amount of protein in the drop. The higher amount of H2O2 compared to solution based 
crystallization was used to increase the probability of hydrogen peroxide reacting with the 
crystallized protein to form a side-on complex. Mr. Yi-Gui Gao aided in the reaction of crystals 
with H2O2 to ensure that the crystals were minimally damaged by the mixing procedure. The 
structure obtained by this procedure is more consistent with an end-on species not a side species. 
5.2.3 Diffraction Data Collection 
The crystals were first soaked briefly in cryoprotectant (30 % polyethylene glycol 400) and were 
flash frozen in liquid nitrogen. The diffraction data sets summarized in Table S1 were collected 
at the National Synchrotron Light Source beamline X12C (Upton, NY) and were processed with 
HKL2000 software18. 
5.2.4 Crystal Structure Determination 
101 
 
The crystal structure was solved by the molecular replacement method using MOLREP in the 
CCP4 Package19. Refinement was performed using X-plor20 and SHELX’9721. For the crystal 
structure of CuBMb, the positions of H43 and H29 were rebuilt using the program O22. For the 
structure of F33Y CuBMb, the position of Y33 was rebuilt using the program O 22. All crystal 
structure determination was performed by Mr. Yi-Gui Gao, of the George L. Clark X-Ray 
Facility and 3M Materials Laboratory, University of Illinois at Urbana-Champaign, as part of a 
collaboration. 
5.2.5 EPR spectroscopy of H2O2-reacted F33Y CuBMb 
EPR spectroscopy of H2O2-reacted F33Y CuBMb consisted of 300 µL of 500 µM protein 
reacting with three eq. H2O2 in 100 mM Tris-HCl (pH 8) while being stirred at room 
temperature. After the reaction, samples were mixed with 20% glycerol and flash-frozen in EPR 
tubes. EPR spectra were collected at 20K and 2mW power. The higher concentration of protein 
was used to maximize potential signals from any new species.  
5.2.6 UV-visible spectroscopy of H2O2-reacted F33Y CuBMb 
All UV-visible spectra were taken using an Agilent 8453 spectrometer (Agilent 
Technologies, Santa Clara, CA) using the supplied Chemstation software and kinetics package. 6 
µM F33Y was reacted with three eq. H2O2 at pH 8 in 100 mM Tris-HCl and pH 6 in 100 mM 
potassium phosphate. The reaction was monitored for one hour. 
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5.3 Results and Discussion 
5.3.1 Obtained crystal structures of H2O2-reacted F33Y CuBMb 
As mentioned above, F33Y CuBMb was reacted with H2O2 for the purpose of inducing a 
His-Tyr crosslink analogous to that in HCOs. The 1.5 Å structure obtained after F33Y CuBMb 
reacted in solution did not contain any evidence of such a covalent bond. The structure did 
contain a side-on bound oxygen species; it is presumably a peroxo species, based on studies by 
Valentine and coworkers12.  The structure obtained by Naruta  and coworkers14 is included for 
comparison as it is also a HCO model system. It should be noted that the Nartura structure is six-
coordinate whereas the F33Y CuBMb structure is seven-coordinate. The two complexes contain 
a side-on bound oxygen species with an oxygen-oxygen bond distance that is too short to be two 
water molecules, and oxygen-iron distances too similar for both oxygen atoms for it to be an 
end-on species. Both structures have another molecule that interacts at least weakly with the 
bound peroxo species. This interaction was not required for the model complexes obtained by 
Valentine and coworkers11 that were based on a Mn(II) side-on structure. For F33Y CuBMb, 
there is a water molecule within hydrogen-bonding distance to both oxygen atoms of the putative 
peroxo species, and His64 may be hydrogen bonding as well. An interesting feature of this 
structure not observed in the met F33Y structure is a water molecule within hydrogen-bonding 
distance of both His43 and Tyr33. This water molecule potentially allows Tyr33 and His43 to 
interact with the bound species via the hydrogen bonding network. The network of hydrogen 
bonds observed apparently stabilizes this intermediate and prevents the expected ferryl 
intermediates from forming.  
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Another structure of F33Y CuBMb reacted with hydrogen peroxide after crystallization. 
This structure was not side-on bound; the ligand appears to be end-on bound. As this structure 
was obtained by reaction in the crystal, it may be a trapped intermediate.  There is a water 
molecule observed in the designed site is in the CuB site, formed by His29, His43, and His64, 
which is similar to what was observed in the met F33Y CuBMb structure in Chapter 2. The 
difference in the water distribution could indicate that the protein is unable to adopt a different 
conformation, or that there is a less occupancy of at water in this end-on structure at the location 
of the water observed in the side-on structure. 
 
 
Figure 5.2  Comparison of F33Y CuBMb hydrogen peroxide structures, (A) The side-on bound F33Y CuBMb 
structure and (B) the F33Y CuBMb end-on structure, (C) Overlay of (A) and(B)  and (D) (TMP)FeIII-(O2)-
(5MeTPA)CuII obtained by Naruta and coworkers. 
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5.3.2 Reaction of  F33Y CuBMb in solution with hydrogen peroxide 
5.3.2.1 UV-visible spectroscopy  
The reaction of F33Y CuBMb with H2O2 was characterized via UV-Vis using a diode 
array spectrometer. The reaction was initiated by adding  three eq of H2O2 to met F33Y CuBMb. 
The addition of hydrogen peroxide cause the Soret band to decrease in intensity and shift to 411 
nm. This is inconsistent with previously reported compound II spectra under these conditions in 
CuBMb17. As the reaction proceeded, a slight shoulder grew in at ~580 nm. When the reaction 
was repeated at pH 6, the reaction initially formed a species similar to that observed at pH 8.  
However, this species converted to a second species with a large shoulder at ~580 nm. This new 
species had a Soret band at ~412 nm, but as the observed spectra was a mixture, it might be more 
red-shifted. It would seem that both reactions starting out similarly, but at lower pH, the 
conversion to a second species was much more rapid.  The visible region of the second species 
had a shape similar to the visible region of a side-on bound species reported by Valentine and 
coworkers in studies with PPIXDME (a heme b analog) and superoxide12,13.  The Soret band, 
however, was blue-shifted by about 20 nm compared to the species reported with PPIXDME. 
This could be due to the additional ligand to the heme or a difference in the environment (a heme 
pocket of a protein versus organic solvent). The reduction of this species by TMPD and 
ascorbate did not produce a deoxyMb species or any significant spectral change, suggesting that 
the species formed under hydrogen peroxide-reacted conditions is not the same as the 411 nm 
oxyMb formed using reductant observed in work described in Chapter 2. 
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Figure 5. 3  UV-Visible spectra of F33Y CuBMb reaction with hydrogen peroxide. Reaction with three equivalents 
H2O2 at (A) pH 8 and (B) pH 6  
5.3.2.2 EPR spectroscopy 
To further characterize the reaction in solution with peroxide, EPR was performed with 
500 uM F33Y CuBMb and three eq. H2O2 at pH 8. The reaction was monitored by taking 
aliquots at various time points, mixing the sample with 20% glycerol, and flash freezing. The 
reaction was monitored for one hour. EPR spectra were collected at 20K and 2mW power, 
conditions that are usually suitable for metMb. An initial sample of metMb was prepared as a 
control, and as a way to determine the signal due to the glycerol-induced conformational change 
in Mb to bis-his ligated, to avoid misinterpretation. As the reaction proceeded, the signal from 
metMb at g  ~ 5.7 decreased as expected. At g ~ 2 and upon addition of H2O2, a peak formed 
that overlapped with a  g ~ 2 peak from  metMb. The peak at g = 2 that originated upon addition 
with H2O2  diminished with time.  A small peak at g  ~ 4.2 was observed that appeared constant 
after H2O2 was added, it did not diminish as the g ~2 peak did.  It should be noted that peaks at 
this position have been assigned to free iron.  Based on the UV-Vis work described above, there 
was no verdoheme formed, usually indicated by a small peak a 678 nm, which would be required 
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in order to degrade the heme and release the iron. Also, Valentine and coworkers10 assigned a 
side-on peroxo species to a signal at this position. Therefore, this signal could be from a side-on 
peroxo, but EPR conditions should be adjusted as the signal intensity is very low.  
 
Figure 5.4 EPR spectroscopy of reaction between F33Y CuBMb and hydrogen peroxide pH 8 
5.4 Summary and Conclusions 
5.4.1 Relation of side-on oxygen species in F33Y CuBMb HCO-like chemistry 
As mentioned above, the UV-visible spectra of the species formed after the reaction with 
hydrogen peroxide is different from the oxyMb species observed when TMPD and ascorbate 
were used (in Chapter 2); also, the addition of reductant does not cause spectra changes. This 
would suggest that the observed species is not able to reduced and cleave the dioxygen bond.  
This does not mean that oxygen chemistry is impossible under these conditions: there could 
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either be a small population that consumes oxygen slowly, or a population that is not active 
spectroscopically overlapping with any active species enough to preclude any observation of the 
relevant spectral changes. Based on Naruta’s precedent of converting a  seven-coordinate side-on 
species to an end-on species15, protonation might convert our species to an intermediate found in 
HCO chemistry. 
5.4.2 Future directions 
The observed side-on species has yet to be spectroscopically characterized as a pure species.  
Efforts are underway to reproduce a side-on bound crystal using both 16O- and 18O-labeled 
hydrogen peroxide.  If successful, UV-visible studies and resonance Raman studies of the 
crystals will provide reference spectra for a side-on bound oxygen in a protein environment, 
potentially providing a new route to confirm the existence of these suggested species in p450s. 
EPR studies at lower temperatures could yield a better signal at g = 4.2 so that these results could 
be more readily compared with studies by Valentine’s lab10. Also, this side-on bound species 
could be better suited for reactions similar to olefin epoxidation reactions described by Valentine 
and coworkers12.  If a substrate were able to enter the heme pocket of myoglobin, it is possible 
that interesting chemistry could be performed by the side-on species. Without mutations 
allowing such a substrate to enter the heme pocket, it may be difficult to observe such activity.  
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